Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Lung Cancer,2010,NCI,5R01CA120174-04,,Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion,"POWELL, CHARLES",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$349,359"
Lung Cancer,2010,NIAID,5R01AI073919-04,,Helicase Regulation of dsRNA Signaling and Innate Antiviral Immune Responses,"HORVATH, CURT",NORTHWESTERN UNIVERSITY,IL,"$382,519"
Lung Cancer,2010,NCI,5R01CA127580-03,,Molecular Mechanisms of EGF Signaling & Iressa/Tarceva Inhibition in NSCLC,"ANDERSON, KAREN",YALE UNIVERSITY,CT,"$323,966"
Lung Cancer,2010,NCI,5R01CA125541-04,,Studies of a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC),"SALGIA, RAVI",UNIVERSITY OF CHICAGO,IL,"$262,485"
Lung Cancer,2010,NCI,5R01CA100603-08,,Regulation and Role of Ornithine Decarboxylase in Cell Proliferation and Cancer,"CLEVELAND, JOHN",SCRIPPS RESEARCH INSTITUTE,CA,"$422,647"
Lung Cancer,2010,NCI,5R01CA122474-03,,Mechanistic Studies on Lung Cancer Prevention by Tea Polyphenols,"YANG, CHUNG",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$319,909"
Lung Cancer,2010,NCI,5R01CA118015-03,,Role of PP2A in Lung Cancer,"WALTER, GERNOT",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$320,588"
Lung Cancer,2010,NCI,5R01CA116697-04,,Oxidative Stress in Cr(VI)-induced Carcinogenesis,"SHI, XIANGLIN",UNIVERSITY OF KENTUCKY,KY,"$278,350"
Lung Cancer,2010,NIGMS,5R01GM076343-05,,Structural Basis of Cytochrome P450 2A13 Activity,"SCOTT, EMILY",UNIVERSITY OF KANSAS LAWRENCE,KS,"$267,893"
Lung Cancer,2010,NCI,5R01CA127219-03,,Inflammation Genes and Lung Cancer Risk,"SPITZ, MARGARET",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$532,744"
Lung Cancer,2010,NCI,5R01CA119028-06,,Mechanisms of As-Induced Carcinogenesis,"SHI, XIANGLIN",UNIVERSITY OF KENTUCKY,KY,"$227,247"
Lung Cancer,2010,NCI,5R01CA113559-05,,The function of RhoBTB proteins,"SOLTOFF, STEPHEN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$293,000"
Lung Cancer,2010,NCI,5R01CA134796-02,,Investigating the role of p73 and its isoforms in tumorigenesis and metastasis,"FLORES, ELSA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$319,550"
Lung Cancer,2010,NCI,5R01CA125030-02,,Small molecule inhibitors of Wnt-2 transcription in NSCLC,"HE, BIAO",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$320,588"
Lung Cancer,2010,NCI,5R01CA078814-12,,New Triterpenoids for Chemoprevention and Therapy of Cancer,"SPORN, MICHAEL",DARTMOUTH COLLEGE,NH,"$351,366"
Lung Cancer,2010,NCI,5R01CA132012-03,,Nanoimmunoliposome-Complexed SPIO: Tumor-Specific Detection of Early Lung Cancer,"CHANG, ESTHER",GEORGETOWN UNIVERSITY,DC,"$630,627"
Lung Cancer,2010,NCI,5R01CA113793-05,,Chemoprevention with mTOR & Farnesyltransferase Inhibitors,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$217,624"
Lung Cancer,2010,NCI,5R01CA127532-03,,Molecular Epidemiology and Lung Cancer: A Nested Case-Control Study,"PERERA, FREDERICA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$403,267"
Lung Cancer,2010,NCI,5R01CA093626-07,,4D IMRT: Stereotactic body radiotherapy for lung cancer,"KEALL, PAUL",STANFORD UNIVERSITY,CA,"$312,504"
Lung Cancer,2010,NCI,5R01CA131049-02,,Prospective Validation of Genomic Signatures of Chemosensitivity in NSCLC,"POTTI, ANIL",DUKE UNIVERSITY,NC,"$323,166"
Lung Cancer,2010,NCI,5F31CA136180-02,,Somatic Mutation Discovery in Lung Squamous Cell Carcinoma,"RAMOS, ALEXIS",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$28,524"
Lung Cancer,2010,NCI,5R01CA113892-05,,Pathways of Therapy-induced Senescence in Cancer,"WU, DANIEL",SEATTLE INST FOR BIOMEDICAL/CLINICAL RES,WA,"$235,952"
Lung Cancer,2010,NCI,5R21CA129260-02,,K-ras Mutations in Mouse Bronchiolar Stem Cells as Biomarkers for Lung Cancer,"KEOHAVONG, PHOUTHONE",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$166,650"
Lung Cancer,2010,NCI,5R01CA116527-04,,Role of JNK Pathway in Lung Tumorigenesis,"HEASLEY, LYNN",UNIVERSITY OF COLORADO DENVER,CO,"$255,132"
Lung Cancer,2010,NCI,5R01CA116020-05,,Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma,"MEYERSON, MATTHEW",DANA-FARBER CANCER INSTITUTE,MA,"$338,027"
Lung Cancer,2010,NCI,5R01CA126969-04,,Assessment of a Teachable Moment for Smoking Cessation,"SCHNOLL, ROBERT",UNIVERSITY OF PENNSYLVANIA,PA,"$311,574"
Lung Cancer,2010,NCI,5R01CA095568-08,,Biomarkers to Assess Selenium Chemoprevention for NSCLC,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$695,549"
Lung Cancer,2010,NCI,5R01CA133021-03,,Inhibition of Lung Carcinogenesis by Tea Polyphenols and Atorvastatin,"YANG, CHUNG",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$319,457"
Lung Cancer,2010,NCI,5R01CA077262-13,,Nucleoporins in Chromosomal Instability and Cancer,"VAN DEURSEN, JAN",MAYO CLINIC,MN,"$312,108"
Lung Cancer,2010,NCI,5R00CA128926-03,,Harnessing Functional Genomics to Reveal Cancer Specific Determinants of Mitosis,"WHITEHURST, ANGELIQUE",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$207,151"
Lung Cancer,2010,NCI,5R01CA121182-04,,Stat3 in EGFR Driven Non-Small Cell Lung Cancer,"HAURA, ERIC",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$317,300"
Lung Cancer,2010,NCI,5R01CA080065-10,,Signaling by Neuregulins and ErbB4 in Breast Cancer,"STERN, DAVID",YALE UNIVERSITY,CT,"$391,179"
Lung Cancer,2010,NCI,5R01CA127105-03,,FGF-2 Autocrine Signaling in Lung Cancer,"HEASLEY, LYNN",UNIVERSITY OF COLORADO DENVER,CO,"$313,657"
Lung Cancer,2010,NCI,5R01CA111851-05,,Novel COX-2 and PGE2-dependent pathways in lung cancer,"DUBINETT, STEVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$239,656"
Lung Cancer,2010,NCI,7R01CA129343-03,,RRM1 in the Management of Lung Cancer,"BEPLER, GEROLD",WAYNE STATE UNIVERSITY,MI,"$567,240"
Lung Cancer,2010,NCI,5R01CA113519-05,,Targeting TGF-beta Signaling in Lung Cancer,"DATTA, PRAN",VANDERBILT UNIVERSITY,TN,"$238,105"
Lung Cancer,2010,NCI,5R01CA128801-02,,Lung carcinogenesis: Chemoprevention by Indole-3-carbinol,"KASSIE, FEKADU",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$250,660"
Lung Cancer,2010,NCI,5R01CA111834-05,,The role of Kras2 in lung tumor susceptibility,"BALMAIN, ALLAN",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$266,285"
Lung Cancer,2010,NHLBI,5F30HL093991-02,,The Role of Sphingosine Kinase 1 in Ras-initiated Lung Carcinogenesis,"GAULT, CHRISTOPHER",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$37,387"
Lung Cancer,2010,NIEHS,5R01ES008801-10,,Tumor Suppressor Gene Methylation in Lung Adenocarcinoma,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$630,707"
Lung Cancer,2010,NCI,5R01CA127725-03,,Role of Beta-arrestin-1 and Src in nAChR Signaling and Lung Caancer,"CHELLAPPAN, SRIKUMAR",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$346,525"
Lung Cancer,2010,NCI,5R01CA122994-04,,Micellar Nanotherapeutics for Targeted Lung Cancer Therapy,"GAO, JINMING",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$268,470"
Lung Cancer,2010,NCI,5R01CA120409-05,,Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells,"JUNE, CARL",UNIVERSITY OF PENNSYLVANIA,PA,"$266,186"
Lung Cancer,2010,NCI,5R01CA100323-07,,Autoantibodies in NSCLC as Markers for Disease,"HIRSCHOWITZ, EDWARD",UNIVERSITY OF KENTUCKY,KY,"$256,375"
Lung Cancer,2010,NCI,5R01CA111766-05,,Molecular Targeting of Drug Delivery System to Cancer,"MINKO, TAMARA",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$266,286"
Lung Cancer,2010,NCI,1R01CA142794-01,,Characterization and therapeutic targeting of HIF in LKB1 - deficient lung cancer,"KIM, WILLIAM",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$305,763"
Lung Cancer,2010,NCI,1R01CA142787-01,,Role of DOK family proteins in lung tumor suppression,"PANDOLFI, PIER PAOLO",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$360,618"
Lung Cancer,2010,NCI,1R01CA142840-01,,Functional Image and Molecular Marker to Individualize Adaptive Radiation Dose Es,"KONG, FENG-MING",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$423,750"
Lung Cancer,2010,NIBIB,5R03EB009182-02,,Preclinical Development and Testing of Multifunctional Tumor-Targeted Hybrid Nano,"RAMESH, RAJAGOPAL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$76,230"
Lung Cancer,2010,NCI,5R01CA129835-03,,LPD Nanoparticles in Anti-Cancer Therapy,"HUANG, LEAF",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$301,885"
Lung Cancer,2010,NCI,5R01CA122244-03,,Randomized trial of PEITC as a modifier of NNK metabolism in smokers,"YUAN, JIAN-MIN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$597,251"
Lung Cancer,2010,NCI,5R01CA126944-03,,Novel Immune Pathways for Lung Cancer Therapy,"SHARMA, SHERVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$287,595"
Lung Cancer,2010,NHLBI,1R21HL098683-01,,Ultrafast Tomosynthesis for Transbronchial Biopsy Guidance,"FAHRIG, REBECCA",STANFORD UNIVERSITY,CA,"$210,000"
Lung Cancer,2010,NCI,1R21CA144063-01,,Predicting the lung ventilation change caused by radiation therapy,"SHENG, KE",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$133,980"
Lung Cancer,2010,NCI,1R21CA143101-01,,Novel Blood Assay for Lung Cancer Detection,"KASSIS, AMIN",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$301,331"
Lung Cancer,2010,NCI,5R01CA124640-04,,Airway gene expression in smokers: an early diagnostic biomarker for lung cancer,"SPIRA, AVRUM",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$308,750"
Lung Cancer,2010,NCI,5R01CA120528-05,,Validation of Prognostic and Diagnostic molecular tests in Mesothelioma,"BUENO, RAPHAEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$301,617"
Lung Cancer,2010,NCI,5R01CA080180-07,,Cancer Risks among Textile Workers in China,"CHECKOWAY, HARVEY",UNIVERSITY OF WASHINGTON,WA,"$560,784"
Lung Cancer,2010,NCI,1U01CA143062-01,,Radiomics of NSCLC,"GATENBY, ROBERT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$621,495"
Lung Cancer,2010,NCI,5R01CA100750-07,,Role of c-Met in SCLC and Potential for Novel Therapy,"SALGIA, RAVI",UNIVERSITY OF CHICAGO,IL,"$248,460"
Lung Cancer,2010,NCI,5R01CA137008-02,,The Activation of ERBB3 Signaling as a Resistance Mechanism to Targeted Therapies,"ENGELMAN, JEFFREY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$352,003"
Lung Cancer,2010,NIAID,1R21AI085513-01,,Adenoviral-based vaccine platform to overcome neutralizing immunity,"GAMBOTTO, ANDREA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$189,375"
Lung Cancer,2010,NCI,5R21CA130349-02,,Telemere Targeted Therapy in Lung Cancer,"EDELMAN, MARTIN",UNIVERSITY OF MARYLAND BALTIMORE,MD,$1
Lung Cancer,2010,NCI,7R01CA117840-04,,Evaluation of Computerized Decision Support for Managing Lung Nodules,"GOULD, MICHAEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$301,168"
Lung Cancer,2010,NCI,5R01CA124495-02,,The Role of RAC1 in Cancer,"KISSIL, JOSEPH",WISTAR INSTITUTE,PA,"$347,148"
Lung Cancer,2010,NCI,1R01CA124951-01A2,,Novel CTD inhibitors with synthetic lethality to oncogenic Ras for cancer therapy,"FANG, BINGLIANG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$310,586"
Lung Cancer,2010,NCI,5R01CA087546-10,,Retinoid Cancer Prevention Mechanisms,"DMITROVSKY, ETHAN",DARTMOUTH COLLEGE,NH,"$273,883"
Lung Cancer,2010,NCI,5R01CA113630-05,,Determinants of Resistance to Erlotinib in NSCLC,"PEREZ-SOLER, ROMAN",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$286,106"
Lung Cancer,2010,NCI,5R01CA077495-12,,Mechanism of Drug Transport in Lung Cancer Cells,"AWASTHI, SANJAY",UNIVERSITY OF NORTH TEXAS HLTH SCI CTR,TX,"$243,821"
Lung Cancer,2010,NCI,5R01CA084354-09,,Genetic Determinants of Lung Cancer Survival,"YANG, PING",MAYO CLINIC,MN,"$316,444"
Lung Cancer,2010,NCI,5R01CA129933-03,,Circumventing Acquired Resistance to Growth Factor Receptor Kinase Inhibitors,"HABER, DANIEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$367,275"
Lung Cancer,2010,NCI,5R01CA131301-02,,Let-7 microRNAs in Lung Cancer: Altering Growth and Radioresistance,"WEIDHAAS, JOANNE",YALE UNIVERSITY,CT,"$338,935"
Lung Cancer,2010,FIC,5D43TW000653-14,,International Training and Research in Environmental and Occupational Health,"HRYHORCZUK, DANIEL",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$113,730"
Lung Cancer,2010,NIEHS,5D43TW000653-14,,International Training and Research in Environmental and Occupational Health,"HRYHORCZUK, DANIEL",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$30,770"
Lung Cancer,2010,NCI,1R01CA136799-01A1,,Regulation of Ras and Rho Family GTPases in Lung Cancer,"WILLIAMS, CAROL",MEDICAL COLLEGE OF WISCONSIN,WI,"$315,400"
Lung Cancer,2010,NCI,1R01CA138759-01A1,,Stat3 Downstream Genes as Lung Adenocarcinoma Biomarkers,"YAN, CONG",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$449,578"
Lung Cancer,2010,NIEHS,5R01ES015662-03,,Mutagenesis of p53 by reactive PAH and ROS,"FIELD, JEFFREY",UNIVERSITY OF PENNSYLVANIA,PA,"$310,381"
Lung Cancer,2010,NCI,5R01CA079882-11,,Targeting the HGF/c-Met Pathway in Lung Cancer,"SIEGFRIED, JILL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$299,617"
Lung Cancer,2010,NCI,1R01CA133253-01A2,,Lung cancer heterogeneity and its impact on drug resistance.,"ALTSCHULER, STEVEN",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$500,950"
Lung Cancer,2010,NCI,5R01CA131261-02,,"Studying the initiation, progression and therapy of lung cancer in mouse models","MCMAHON, MARTIN",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$352,223"
Lung Cancer,2010,NCI,1P01CA138338-01A1,7507,Multiethnic Genome Scan of Metabolic Phenotypes,"LE MARCHAND, LOIC",UNIVERSITY OF HAWAII,HI,"$1,030,073"
Lung Cancer,2010,NCI,1P01CA138338-01A1,7509,Nicotine and NNK Glucuronidation Pathways on Smokers,"MURPHY, SHARON",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$74,009"
Lung Cancer,2010,NCI,1P01CA138338-01A1,7511,"Ethnic/Racial Differences in 1, 3-Bitadiene Metabolism and DNA Adduct Formation","TRETYAKOVA, NATALIA",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$136,574"
Lung Cancer,2010,NCI,1P01CA138338-01A1,7512,Ethnic/Racial Differences in DNA Repair,"PETERSON, LISA",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$123,193"
Lung Cancer,2010,NCI,1P01CA138338-01A1,7514,Metabolism of NNK among African Americans,"HATSUKAMI, DOROTHY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$145,250"
Lung Cancer,2010,NCI,1P01CA138338-01A1,7515,Administratice Core,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$32,224"
Lung Cancer,2010,NCI,1P01CA138338-01A1,7516,Tobacco Smoke Constituent Biomarker Core,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$161,601"
Lung Cancer,2010,NCI,1P01CA138338-01A1,7517,Biostatistics Core,"STRAM, DANIEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$248,580"
Lung Cancer,2010,NCI,1R01CA140409-01A1,,Development of Small Molecule Radiation Sensitizers,"FREEMAN, MICHAEL",VANDERBILT UNIVERSITY,TN,"$358,801"
Lung Cancer,2010,NCI,1R21CA141139-01A1,,Detection of Lung Cancer Risks for Serum Metabolomics,"CHENG, LEO",MASSACHUSETTS GENERAL HOSPITAL,MA,"$247,666"
Lung Cancer,2010,NHLBI,5R01HL086598-04,,Epidermal Growth Factor Receptor Activation in Pulmonary Fibrosis,"HARDIE, WILLIAM",CHILDREN'S HOSPITAL MED CTR (CINCINNATI),OH,"$375,000"
Lung Cancer,2010,NCI,5R01CA132603-03,,Mechansims of Lung Carcinogenesis Induced by Asbestos and Cigarette Smoke,"SULLIVAN, DEBORAH",TULANE UNIVERSITY OF LOUISIANA,LA,"$285,906"
Lung Cancer,2010,NCI,1R01CA144034-01,,Prospective studies of cancer etiology and prevention in Shanghai and Singapore,"YUAN, JIAN-MIN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$1,546,796"
Lung Cancer,2010,NCI,5R01CA129533-03,,Molecular Characterization of Stage I Lung Cancer,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$327,628"
Lung Cancer,2010,NCI,5R01CA126939-03,,The Epidemiology of Molecular Alterations in Mesothelioma,"KELSEY, KARL",BROWN UNIVERSITY,RI,"$493,577"
Lung Cancer,2010,NCI,5R01CA096679-06,,LUNG TRAJECTORY MAPPING FOR RADIATION THERAPY,"LOW, DANIEL",WASHINGTON UNIVERSITY,MO,"$306,143"
Lung Cancer,2010,NCI,5R01CA104932-05,,Lycopene Chemoprevention of Lung Cancer in Ferret,"WANG, XIANG-DONG",TUFTS UNIVERSITY BOSTON,MA,"$272,318"
Lung Cancer,2010,NCI,5R03CA135701-02,,Groundwork for a study of non-smoking-associated lung cancer in AsianPacific Isla,"CHANG, ELLEN",CANCER PREVENTION INSTIT OF CALIFORNIA,CA,"$72,500"
Lung Cancer,2010,NCI,5R01CA132586-03,,Pulmonary inflammation and lung cancer development and progression,"KARIN, MICHAEL",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$338,259"
Lung Cancer,2010,NIEHS,5R01ES014872-05,,Oxidative DNA Lesion Formation from Chromate Exposure,"SUGDEN, KENT",UNIVERSITY OF MONTANA,MT,"$246,926"
Lung Cancer,2010,NIDCR,5R01DE013123-09,,Genomic Scanning for Generic and Epigenetic Alterations in head and neck cancer,"PLASS, CHRISTOPH",GERMAN CANCER RESEARCH CENTER,GERM,"$259,281"
Lung Cancer,2010,NCI,1K24CA139054-01A1,,"Risk for Lung Cancer, Asthma, and COPD; Integrating Clinical and Airway Biomarker","SPIVACK, SIMON",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$167,705"
Lung Cancer,2010,NCI,5R01CA132566-03,,Inflammation and Lung Carcinogenesis,"JABLONS, DAVID",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$293,550"
Lung Cancer,2010,NCI,5R01CA132608-03,,Inflammation in Oncogenic K-ras-induced Lung Tumorigenesis,"KURIE, JONATHAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$263,340"
Lung Cancer,2010,NCI,5U01CA069856-16,,Early Clinical Trials of New Anti-Cancer Agents with Phase 1 Emphasis,"SPRIGGS, DAVID",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$258,850"
Lung Cancer,2010,NCI,5R01CA116158-04,,Relationship of Colon & Lung Cancer Susceptibility Genes,"DEMANT, PETER",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$320,064"
Lung Cancer,2010,NCI,5R01CA039504-24,,Aldo-Keto Reductases and PAH Metabolism/Activation,"PENNING, TREVOR",UNIVERSITY OF PENNSYLVANIA,PA,"$289,179"
Lung Cancer,2010,NCI,5K08CA120060-05,,Molecular mechanisms of PI3K activation in non-small cell lung cancer,"ENGELMAN, JEFFREY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$143,775"
Lung Cancer,2010,NCI,5R01CA118130-03,,PET Proliferation Tracers,"SCHWARTZ, JEFFREY",UNIVERSITY OF WASHINGTON,WA,"$376,166"
Lung Cancer,2010,NCI,5R01CA102792-08,,Use of Beta-lapachone for Lung Cancer Chemotherapy,"BOOTHMAN, DAVID",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$341,159"
Lung Cancer,2010,NCI,5R01CA113450-03,,Systemic Non-Viral Gene Therapy for Cancer,"RAMESH, RAJAGOPAL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$319,550"
Lung Cancer,2010,NCI,5R01CA116322-04,,Tumor and PTK-Targeted Therapy by FUS1 and PTK inhibitor,"JI, LIN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$292,600"
Lung Cancer,2010,NCI,5R01CA132571-03,,Regulation of Tumor Associated Macrophages by TGF-beta,"KESHAMOUNI, VENKATESHWAR",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$287,283"
Lung Cancer,2010,NIGMS,1R43GM090343-01,,Regulation signatures for predicting drug resistance and its molecular mechanisms,"BUGRIM, ANDREJ","GENEGO, INC.",MI,"$175,768"
Lung Cancer,2010,NCI,5R01CA126993-03,,Respiratory Motion-Reduced Cone-Beam CT Guidance of Radiotherapy in Lung & Liver,"MAGERAS, GIKAS",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$535,456"
Lung Cancer,2010,NCI,5R01CA134541-03,,INCORPORATING REAL-TIME LOCALIZATION  IN RADIATION THERAPY PLANNING AND DELIVERY,"PARIKH, PARAG",WASHINGTON UNIVERSITY,MO,"$279,013"
Lung Cancer,2010,NCI,5R01CA132552-03,,Lung tumor associated macrophages,"MALKINSON, ALVIN",UNIVERSITY OF COLORADO DENVER,CO,"$290,858"
Lung Cancer,2010,NCI,5R01CA124378-12,,Role of Mitotic Checkpoint Defects in Mouse Tumor Models,"BENEZRA, ROBERT",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$295,390"
Lung Cancer,2010,NCI,5K23CA115908-05,,Symptom Management Trial in Cancer Survivors,"PIRL, WILLIAM",MASSACHUSETTS GENERAL HOSPITAL,MA,"$141,345"
Lung Cancer,2010,NCI,7R01CA139159-02,,Signal Transduction Enzyme Inhibitors from Extremophilic Microbes as Anticancer A,"STIERLE, ANDREA",UNIVERSITY OF MONTANA,MT,"$215,936"
Lung Cancer,2010,NCI,5R01CA089352-09,,Mechanisms of thymide phosphorylase angiogenesis,"SCHWARTZ, EDWARD","MONTEFIORE MEDICAL CENTER (BRONX, NY)",NY,"$231,766"
Lung Cancer,2010,NIEHS,5R01ES017217-02,,Mdig gene and histone demethylation in lung cancer,"CHEN, FEI",UNIVERSITY OF KENTUCKY,KY,"$293,696"
Lung Cancer,2010,NCI,1R43CA144821-01,,Development of mutant selective EGFR kinase inhibitors against EGFR T790M,"CHANT, JOHN","GATEKEEPER PHARMACEUTICALS, INC.",CA,"$294,778"
Lung Cancer,2010,NCI,5R01CA132580-03,,Inflammatory Cytokines Link NF-kappaB with Bim Degradation and Metastasis,"MAYO, MARTY",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$284,834"
Lung Cancer,2010,NCI,5R01CA132624-03,,Macrophages and Inflammatory Mediators in Silica-Induced Carcinogenesis,"LASKIN, DEBRA",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$293,731"
Lung Cancer,2010,NIEHS,5R01ES015857-04,,Pathways of PAH activation in human lung cells,"PENNING, TREVOR",UNIVERSITY OF PENNSYLVANIA,PA,"$355,448"
Lung Cancer,2010,NIDCR,5R01DE013158-10,,UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK,"LAZARUS, PHILIP",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$507,677"
Lung Cancer,2010,NCI,5R01CA129011-03,,Ultra-Sensitive MR Probes for Molecular Diagnosis of Lung Cancer,"GAO, JINMING",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$325,775"
Lung Cancer,2010,NCI,5R01CA117965-05,,Mediators of Oncogenic KRAS in Lung Adenocarcinoma,"KURIE, JONATHAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$258,530"
Lung Cancer,2010,NCI,5R01CA125564-04,,Urokinase Receptor Integrin Interactions in Lung Cancer,"CHAPMAN, HAROLD",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$293,550"
Lung Cancer,2010,NCI,5R01CA094188-09,,Oncogenesis By Jaagsiekte Sheep Retrovirus,"FAN, HUNG",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$334,301"
Lung Cancer,2010,NCI,5R01CA129501-03,,Role of Paxillin in Lung Cancer,"SALGIA, RAVI",UNIVERSITY OF CHICAGO,IL,"$327,534"
Lung Cancer,2010,NCI,5R01CA129364-03,,Role of EGFR in DNA Repair and Radiation Response in Non Small Cell Lung Cancer,"NIRODI, CHAITANYA",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$260,620"
Lung Cancer,2010,NCI,5R01CA134682-02,,Genome-Wide Association Studies of Inherited Predisposition to Lung Cancer,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$421,077"
Lung Cancer,2010,NCI,5R01CA131044-03,,NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases,"COLSON, YOLONDA",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$360,905"
Lung Cancer,2010,NCI,5R01CA124490-04,,Role of Nicotine in Lung Carcinogenesis,"CHEN, CHANGYAN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$323,000"
Lung Cancer,2010,NCI,5R01CA068682-20,,Biomedical Applications of Expanded Porphyrins,"SESSLER, JONATHAN",UNIVERSITY OF TEXAS AUSTIN,TX,"$305,354"
Lung Cancer,2010,NCI,5R01CA132591-03,,Role of DOK Proteins in Lung Cancer,"NIKI, MASARU",UNIVERSITY OF IOWA,IA,"$285,000"
Lung Cancer,2010,NCI,5R01CA136910-02,,Effects of Low Dose CT Radiation on Lung Tumorigenesis,"MUNLEY, MICHAEL",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$461,531"
Lung Cancer,2010,NCI,5K07CA123109-04,,"Bayesian Hierarchical Risk Models: Nutrition, Genes, & Environment Interactions","SWARTZ, MICHAEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$135,637"
Lung Cancer,2010,NCI,5R01CA122794-05,,EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors,"WONG, KWOK KIN",DANA-FARBER CANCER INSTITUTE,MA,"$277,591"
Lung Cancer,2010,NCI,5R01CA125256-03,,A lung cancer symptom assessment and management intervention,"COOLEY, MARY",DANA-FARBER CANCER INSTITUTE,MA,"$450,638"
Lung Cancer,2010,NIEHS,5R01ES008786-13,,Genotoxicity of Chromium Compounds,"ZHITKOVICH, ANATOLY",BROWN UNIVERSITY,RI,"$360,763"
Lung Cancer,2010,NCI,5K22CA123104-04,,The role of EP4 in fibronectin-induced human lung cancer cell growth,"HAN, SHOUWEI",UNIVERSITY OF LOUISVILLE,KY,"$134,763"
Lung Cancer,2010,NCI,5R01CA101880-06,,Novel DNA-metalating Hybrid Anticancer Agents,"BIERBACH, ULRICH",WAKE FOREST UNIVERSITY,NC,"$231,408"
Lung Cancer,2010,NCI,5R01CA135358-03,,Targeted liposomal radiotherapy of malignant mesothelioma,"HE, JIANG",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$259,432"
Lung Cancer,2010,NIEHS,5F31ES016719-03,,Curcumin inhbits BPDE-induced damage by lowering the threshold of p53 activation,"ROGERS, ERICA",UNIVERSITY OF LOUISVILLE,KY,"$24,118"
Lung Cancer,2010,NIEHS,1P20ES018169-01,5327,"Project 3: Human Fetal Lung, Arsenic Exposure,  Tissue Remodeling","DEPAEPE, MONIQUE",BROWN UNIVERSITY,,"$61,035"
Lung Cancer,2010,NIEHS,5R01ES014399-04,,Genetic Modifiers of Lung Cancer,"WANG, YIAN",WASHINGTON UNIVERSITY,MO,"$331,808"
Lung Cancer,2010,NCI,5R01CA118200-04,,Management of Breathing effects in Radiotherapy Planning,"BORTFELD, THOMAS",MASSACHUSETTS GENERAL HOSPITAL,MA,"$319,390"
Lung Cancer,2010,NCI,5R01CA113448-05,,EGFR/Radiation Response and Resistance Interactions,"HARARI, PAUL",UNIVERSITY OF WISCONSIN MADISON,WI,"$253,359"
Lung Cancer,2010,NCI,5R01CA120869-04,,DNA Methylation Changes During Development and Progression of Lung Adenocarcinoma,"LAIRD-OFFRINGA, ITE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$308,995"
Lung Cancer,2010,NCI,5R01CA115857-05,,Health and QOL among Long-Term Lung Cancer Survivors,"YANG, PING",MAYO CLINIC,MN,"$481,385"
Lung Cancer,2010,NCI,5K23CA131577-02,,Gene Modified Dendritic Cell Therapy in Lung Cancer,"LEE, JAY",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$132,031"
Lung Cancer,2010,NCI,5R01CA092025-09,,Benzo[a]pyrene metabolism: phenotyping and genotyping,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$338,679"
Lung Cancer,2010,NIEHS,5R01ES014032-04,,Incident cancer studies in a unique arsenic-exposed area of Chile,"STEINMAUS, CRAIG",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$375,270"
Lung Cancer,2010,NCI,5R01CA121197-04,,High Density Association Analysis of Lung Cancer,"AMOS, CHRISTOPHER",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$386,698"
Lung Cancer,2010,NCI,1R01CA148722-01,,Imaging Cellular Stress and Treatment Response Using Positron Emission Tomography,"SHIELDS, ANTHONY",WAYNE STATE UNIVERSITY,MI,"$318,139"
Lung Cancer,2010,NCI,5R01CA100816-06,,Novel Strategy for Lung Cancer Treatment Using IGF-1R Inhibitor,"LEE, HO-YOUNG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$251,447"
Lung Cancer,2010,NCI,5R01CA135257-03,,Drug Resistance in Lung Cancer,"JANNE, PASI",DANA-FARBER CANCER INSTITUTE,MA,"$358,976"
Lung Cancer,2010,NCI,5R01CA134433-02,,MOLECULAR GENETICS OF LUNG TUMOR PROMOTION IN MICE,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$315,400"
Lung Cancer,2010,NCI,5R01CA139959-02,,CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E,"WANG, YIAN",WASHINGTON UNIVERSITY,MO,"$239,400"
Lung Cancer,2010,OD,5R01CA139959-02,,CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E,"WANG, YIAN",WASHINGTON UNIVERSITY,MO,"$76,000"
Lung Cancer,2010,NCI,5R01CA092039-07,,GENETICS OF TOBACCO AND ALCOHOL RELATED CANCERS,"BRENNAN, PAUL",INTERNATIONAL AGENCY FOR RES ON CANCER,FR,"$450,691"
Lung Cancer,2010,NCI,1R01CA149668-01,,Targeting apoptosis via chemical design of Bcl-2 antagonists,"PELLECCHIA, MAURIZIO",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$396,325"
Lung Cancer,2010,NCI,1R01CA149462-01,,A genomewide study of lung cancer in never smokers,"GORLOVA, OLGA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$1,888,628"
Lung Cancer,2010,NCI,5R01CA134503-02,,Notch-1 and IGF-1 crosstalk: new therapeutic strategies for NSCLC,"BOCCHETTA, MAURIZIO",LOYOLA UNIVERSITY CHICAGO,IL,"$310,213"
Lung Cancer,2010,NCI,5R01CA116812-04,,Lung extracellular matrix and tumor progression,"ROMAN, JESSE",UNIVERSITY OF LOUISVILLE,KY,"$309,175"
Lung Cancer,2010,NCI,5R01CA106314-07,,Dmp1-p53/YY1 interplays and their roles in lung cancer development,"INOUE, KAZUSHI",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$266,677"
Lung Cancer,2010,NCI,5R01CA105155-07,,Kinase Signaling in Lung Tumorigenesis,"KURIE, JONATHAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$251,447"
Lung Cancer,2010,NCI,5K24CA120494-04,,K24 Mid-Career Investigator Award in Patient-Oriented Research,"SILVESTRI, GERARD",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$145,649"
Lung Cancer,2010,NCI,1R21CA150297-01,,MicroRNA Expression in Lung Cancer Development and Progression,"NANA-SINKAM, SERGE",OHIO STATE UNIVERSITY,OH,"$165,844"
Lung Cancer,2010,NIEHS,5R01ES015262-03,,Genetic and Epigenetic Biomarkers for SCC of the Lung,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$704,377"
Lung Cancer,2010,NCI,5R01CA129610-03,,Mechanism and role of DLC-1 tumor suppressor loss in lung cancer,"DER, CHANNING",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$305,763"
Lung Cancer,2010,NIEHS,1R03ES018919-01,,Impact of transplacental PAH exposure on the epigenome,"BENNINGHOFF, ABBY",UTAH STATE UNIVERSITY,UT,"$70,000"
Lung Cancer,2010,NCI,5K05CA092002-07,,Mentoring and Research in Cancer Epidemiology,"WEISS, NOEL",UNIVERSITY OF WASHINGTON,WA,"$156,254"
Lung Cancer,2010,NCI,7R01CA125143-04,,Advanced Anatomic and Functional Response Assessment in Lung Cancer,"SCHWARTZ, LAWRENCE",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$307,531"
Lung Cancer,2010,NCI,5R01CA136765-02,,Genetic determinants associated with pemetrexed response and toxicity,"DOLAN, M",UNIVERSITY OF CHICAGO,IL,"$329,867"
Lung Cancer,2010,NCI,5R01CA127547-03,,Identification and characterization of driver gene(s) in recurrent lung cancer am,"MU, DAVID",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$289,649"
Lung Cancer,2010,NIEHS,5R01ES016284-03,,BIOMARKERS OF EXPOSURE AND EFFECT IN A TRAFFIC EXPOSED POPULATION,"LADEN, FRANCINE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$713,888"
Lung Cancer,2010,NCI,2U54CA112962-06,,Broad Institute Center for Cancer Systems Biology,"GOLUB, TODD","BROAD INSTITUTE, INC.",MA,"$2,222,285"
Lung Cancer,2010,NCI,5R01CA136705-02,,Epigenetic and post-translational regulation of the metastasis suppressor BRMS1,"JONES, DAVID",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$314,363"
Lung Cancer,2010,NCI,5R01CA126818-03,,HDGF: a novel biomarker and therapetic target of lung cancer,"MAO, LI",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$311,250"
Lung Cancer,2010,NCI,5R03CA137819-02,,ROLE OF AP-1 IN THE CHEMOPREVENTIVE FUNCTION OF GREEN TEA IN VIVO,"TICHELAAR, JAY",WASHINGTON UNIVERSITY,MO,"$15,200"
Lung Cancer,2010,NCI,5R01CA125653-04,,Circulating Tumor Cells in Non-Small Cell Lung Cancer,"NIEVA, JORGE",BILLINGS CLINIC FOUNDATION,MT,"$337,278"
Lung Cancer,2010,NCI,5R03CA136054-02,,The Daily Experience of Somatic Anxiety and Worry in Lung Cancer Survivors,"ARONSON, KEITH",PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,PA,"$75,779"
Lung Cancer,2010,NCI,5R01CA129632-04,,microRNA regulation of drug sensitivity in non-small cell lung cancer,"PERTSEMLIDIS, ALEXANDER",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$236,592"
Lung Cancer,2010,NCI,5K01CA128823-04,,Folate Metabolism & Methylation in Lung Cancer,"FLORES, KRISTINA",UNIVERSITY OF NEW MEXICO,NM,"$136,894"
Lung Cancer,2010,NCI,7R03CA139862-02,,Psychosocial Support Needs and Preferences of Caregivers of Lung Cancer Patients,"MOSHER, CATHERINE",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$77,000"
Lung Cancer,2010,NCI,5R01CA124967-04,,High Resolution Optical Coherence Tomography for Early Airway Cancer Detection,"BRENNER, MATTHEW",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$260,775"
Lung Cancer,2010,NIEHS,1R01ES017009-01A2,,Nicotinic Receptor Ligands and Tobacco-induced Lung Cancer,"GRANDO, SERGEI",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$344,250"
Lung Cancer,2010,NCI,5R01CA131348-03,,Prognosis and Effectiveness of Advanced Lung Cancer Treatment in the Elderly,"WISNIVESKY, JUAN",MOUNT SINAI SCHOOL OF MEDICINE,NY,"$258,064"
Lung Cancer,2010,NIEHS,5R21ES017494-02,,Developing a murine model for arsenic-induced skin neoplasm,"ATHAR, MOHAMMAD",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$181,294"
Lung Cancer,2010,NIEHS,5R21ES017307-02,,Allergic asthma and chromium exposure,"CONSTANT, STEPHANIE",GEORGE WASHINGTON UNIVERSITY,DC,"$193,669"
Lung Cancer,2010,NIEHS,5R03ES016605-02,,Effects of Lactational Exposure to Chromium (VI) on Ovarian Development,"BANU, SAKHILA",TEXAS A&M UNIVERSITY SYSTEM,TX,"$72,518"
Lung Cancer,2010,NCI,1P50CA148596-01,6423,IMPACT: INFLUENCING MEDIA & PUBLIC AGENDA ON CANCER & TOBACCO DISPARITIES,"VISWANATH, VISH",HARVARD SCHOOL OF PUBLIC HEALTH,,"$670,326"
Lung Cancer,2010,NCI,1P50CA148596-01,6424,TOBACCO TREATMENT OUTREACH TO REDUCE DISPARITIES FOR PRIMARY CARE POPULATIONS,"HAAS, JENNIFER",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$290,686"
Lung Cancer,2010,NCI,1P50CA148596-01,6425,RACIAL AND SOCIOECONOMIC DISPARITIES IN LUNG CANCER: A MULTIFACTORIAL ANALYSIS,"AYANIAN, JOHN",HARVARD SCHOOL OF PUBLIC HEALTH,,"$99,149"
Lung Cancer,2010,NCI,1P50CA148596-01,6426,RACIAL DIFFERENCES IN LUNG ADENOCARCINOMA MUTATIONS,"MYERSON, MATTHEW",HARVARD SCHOOL OF PUBLIC HEALTH,,"$210,899"
Lung Cancer,2010,NCI,1P50CA148596-01,6427,SOCIOECONOMIC ADJUSTMENT OF RACIAL DISPARITIES IN LUNG CANCER RELATIVE SURVIVAL,"CHEN, JARVIS",HARVARD SCHOOL OF PUBLIC HEALTH,,"$51,190"
Lung Cancer,2010,NCI,1P50CA148596-01,6428,ADMINISTRATIVE,"WILLIAMS, DAVID",HARVARD SCHOOL OF PUBLIC HEALTH,,"$305,843"
Lung Cancer,2010,NCI,1P50CA148596-01,6429,METHODS AND STATISTICS,"ZASLAVSKY, ALAN",HARVARD SCHOOL OF PUBLIC HEALTH,,"$8,745"
Lung Cancer,2010,NCI,1P50CA148596-01,6430,PILOT PROJECTS,"WILLIAMS, DAVID",HARVARD SCHOOL OF PUBLIC HEALTH,,"$47,765"
Lung Cancer,2010,NCI,1P50CA148596-01,6431,DISSEMINATION AND PUBLIC HEALTH PRACTICE,"GELLER, ALAN",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$8,028"
Lung Cancer,2010,NCI,1P50CA148596-01,6432,TRAINING AND CAREER DEVELOPMENT,"SORENSEN, GLORIAN",DANA-FARBER CANCER INSTITUTE,MA,"$21,805"
Lung Cancer,2010,NCI,5R01CA121210-04,,Overcoming acquired resistance to EGFR inhibitors in lung cancer,"PAO, WILLIAM",VANDERBILT UNIVERSITY,TN,"$265,050"
Lung Cancer,2010,NCI,5R37CA081301-12,,Metabolism of Carcinogenic Tobacco-Specific Nitrosamines,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$518,916"
Lung Cancer,2010,NCI,5K23CA122182-03,,Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer,"NWOGU, CHUKWUMERE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$148,505"
Lung Cancer,2010,NIEHS,5F30ES017730-02,,Y-family DNA polymerases and cellular responses to benzo[a]pyrene,"KLARER, ALDEN",UNIVERSITY OF LOUISVILLE,KY,"$28,171"
Lung Cancer,2010,NCI,2P01CA090890-06A2,6522,Transplacental Chemoprevention of Lung Tumors and Lymphomas,"WILLIAMS, DAVID",OREGON STATE UNIVERSITY,OR,"$227,169"
Lung Cancer,2010,NIEHS,5R01ES016893-02,,Particulate Cr(VI) Toxicology in Human Lung Epithelial Cells and Fibroblasts,"WISE, JOHN",UNIVERSITY OF SOUTHERN MAINE,ME,"$333,011"
Lung Cancer,2010,NCI,5R01CA136635-02,,ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS,"MAO, LI",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$311,250"
Lung Cancer,2010,NCI,2R01CA073756-11A1,,Ras-Induced Lung Cancer: Key Roles for IKK and NF-kappaB,"BALDWIN, ALBERT",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$260,174"
Lung Cancer,2010,NCI,1R01CA129491-01A2,,Identifying antigens bound by novel scFvs targeting all subtypes of mesothelioma,"LIU, BIN",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$320,588"
Lung Cancer,2010,NCI,1R01CA126801-01A2,,Role of CREB in Lung Cancer Development,"KOO, JA SEOK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$327,850"
Lung Cancer,2010,NCI,1R01CA140515-01A1,,Tyrosine Kinase Signaling in Cancer Cell Metabolism,"CHEN, JING",EMORY UNIVERSITY,GA,"$324,703"
Lung Cancer,2010,NCI,1R01CA140416-01A1,,Antifolate activators of AMP-dependent protein kinase,"MORAN, RICHARD",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$289,984"
Lung Cancer,2010,NCI,2R01CA097356-06A1,,Factors for Epigenetic Silencing of Lung Cancer Genes,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$1,402,455"
Lung Cancer,2010,NCI,1R01CA141144-01A1,,Fibroblast Activation Protein in the Tumor Microenvironment in Lung Cancer,"PURE', ELLEN",WISTAR INSTITUTE,PA,"$339,621"
Lung Cancer,2010,NCI,2R01CA102353-05A2,,Molecular Approaches to Early Detection of Lung Cancer,"MASSION, PIERRE",VANDERBILT UNIVERSITY,TN,"$216,242"
Lung Cancer,2010,NCI,5K01CA124581-04,,Racial disparities in the treatment of lung cancer in African Americans,"LATHAN, CHRISTOPHER",DANA-FARBER CANCER INSTITUTE,MA,"$160,767"
Lung Cancer,2010,NCI,5R01CA140991-02,,Targeting Glucose Metabolism in Cancer,"TELANG, SUCHETA",UNIVERSITY OF LOUISVILLE,KY,"$184,260"
Lung Cancer,2010,NCI,1R01CA140492-01A1,,Regulation of Tumorigenesis and therapeutic resistance by Nrf2 in lung cancer,"BISWAL, SHYAM",JOHNS HOPKINS UNIVERSITY,MD,"$338,324"
Lung Cancer,2010,NCI,5R01CA076354-10,,A mouse model of stem cell deregulation and lung cancer,"LOCKER, JOSEPH",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$264,921"
Lung Cancer,2010,NCI,5R03CA141998-02,,A Novel Bayesian Model Averaging Approach for Genome Wide Association Studies,"SWARTZ, MICHAEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$77,000"
Lung Cancer,2010,NHLBI,5R01HL090483-04,,The Study of HIV Infection in the Etiology of Lung Disease (SHIELD),"KIRK, GREGORY",JOHNS HOPKINS UNIVERSITY,MD,"$873,129"
Lung Cancer,2010,NCI,5R33CA127055-04,,CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer,"HERMAN, JAMES",JOHNS HOPKINS UNIVERSITY,MD,"$270,600"
Lung Cancer,2010,NCI,5R01CA129534-02,,Biomarkers of NNK in prediction of lung cancer development in smokers,"YUAN, JIAN-MIN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$582,849"
Lung Cancer,2010,NCRR,5K01RR021879-05,,Regulation of PTHrP in Squamous Cell Carcinoma by the EGF Receptor,"LORCH, GWENDOLEN",OHIO STATE UNIVERSITY,OH,"$126,900"
Lung Cancer,2010,NCI,5R01CA095039-07,,Sequence distribution of tobacco carcinogen-DNA adducts,"TRETYAKOVA, NATALIA",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$225,787"
Lung Cancer,2010,NCI,5R01CA088932-09,,Regulation of Telomerase by Ceramide in Lung Cancer,"OGRETMEN, BESIM",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$207,232"
Lung Cancer,2010,NCI,5R01CA138256-03,,Comparative functional genomics for lung cancer gene discovery,"SWEET-CORDERO, ERIC",STANFORD UNIVERSITY,CA,"$569,332"
Lung Cancer,2010,NCI,5R01CA118434-03,,Biochemical Mechanisms of Se Anticancer Activity in Lung,"FAN, TERESA",UNIVERSITY OF LOUISVILLE,KY,"$307,100"
Lung Cancer,2010,NIA,5K08AG031583-03,,Continuity of care and end of the life ICU use,"SHARMA, GULSHAN",UNIVERSITY OF TEXAS MEDICAL BR GALVESTON,TX,"$119,610"
Lung Cancer,2010,NCI,5R33CA140039-02,,A multiplex genome-wide shRNA screening platform for cancer-lethal gene discovery,"ELLEDGE, STEPHEN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$359,748"
Lung Cancer,2010,NCI,5R01CA133470-03,,Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy,"CHRISTOFIDOU-SOLOMIDOU, MELPO",UNIVERSITY OF PENNSYLVANIA,PA,"$319,654"
Lung Cancer,2010,NCI,1R03CA141483-01A1,,Investigating the Role of HPV in Lung Cancer,"RAGIN, CAMILLE",SUNY DOWNSTATE MEDICAL CENTER,NY,"$79,375"
Lung Cancer,2010,NIEHS,1R01ES017777-01A1,,The Epigenetic Mechanism of Arsenic Lung Carcinogenesis - Role of MicroRNAs,"YANG, CHENGFENG",MICHIGAN STATE UNIVERSITY,MI,"$354,150"
Lung Cancer,2010,NIEHS,1R21ES017496-01A1,,Role of the tumor suppressor Fus1 in asbestos-induced inflammatory cancers,"IVANOVA, ALLA",VANDERBILT UNIVERSITY,TN,"$193,750"
Lung Cancer,2010,NCI,5R01CA121144-03,,Chemoresistance and Motility: Role of Mutant p53 and NF-kB2 in Cancer,"DEB, SUMITRA",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$248,170"
Lung Cancer,2010,NCI,2R01CA109038-05A1,,"NKX2-1, A Candidate Lineage Survival Oncogene in Lung Adenocarcinoma","MEYERSON, MATTHEW",DANA-FARBER CANCER INSTITUTE,MA,"$434,583"
Lung Cancer,2010,NCI,1R01CA142842-01A1,,Sensitive and Specific Molecular Imaging of Pulmonary Nodules,"DRIEHUYS, BASTIAAN",DUKE UNIVERSITY,NC,"$332,089"
Lung Cancer,2010,NCI,5K07CA111952-05,,Molecular epidemiology of lung cancer,"VACHANI, ANIL",UNIVERSITY OF PENNSYLVANIA,PA,"$138,429"
Lung Cancer,2010,NCI,5R01CA135405-03,,Transition State Analogues as Modulators of DNA Methylation,"SCHRAMM, VERN",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$270,000"
Lung Cancer,2010,NCI,5R01CA092824-08,,Molecular and Genetic Analysis of Lung Cancer Survival,"CHRISTIANI, DAVID",HARVARD UNIVERSITY (SCH OF PUBLIC HLTH),MA,"$590,122"
Lung Cancer,2010,NCI,5R01CA129022-04,,Precise Correspondence of 3D Pathology with Radiological Features in Lung Nodules,"KLINE, JOEL",UNIVERSITY OF IOWA,IA,"$350,135"
Lung Cancer,2010,NCI,5R01CA068377-14,,The Physiological Function and Regulation of INK4 Genes,"XIONG, YUE",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$326,778"
Lung Cancer,2010,NCI,5R01CA119029-05,,Development of DNA Methylation Markers for Early Detection of Lung Cancer,"LAIRD-OFFRINGA, ITE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$319,198"
Lung Cancer,2010,NHLBI,5K08HL085286-05,,"Interrelationships Between COPD, Inflammation, and Lung Tumorigenesis","HOUGHTON, A. MCGARRY",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$126,225"
Lung Cancer,2010,NCI,5R01CA120188-04,,"Integrin avb3 targeted drug design, delivery, and imaging","NEAMATI, NOURI",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$213,288"
Lung Cancer,2010,NCI,5F31CA142164-02,,Mechanisms of Lung Cancer,"TORMOS, KATHRYN",NORTHWESTERN UNIVERSITY,IL,"$28,326"
Lung Cancer,2010,NCI,5R01CA108467-06,,BIOMOLECULAR ANALYSIS USING LIQUID CRYSTALS,"ABBOTT, NICHOLAS",UNIVERSITY OF WISCONSIN MADISON,WI,"$438,944"
Lung Cancer,2010,NCI,5R00CA126147-04,,Developing approaches for modeling genomic and proteomic profiles in lung cancer,"MCMAHON, PAMELA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$242,017"
Lung Cancer,2010,NCI,5R01CA132847-02,,Role and mechanism of action of p62/Sqstm1 in Ras-induced tumorigenesis in lung,"MOSCAT, JORGE",UNIVERSITY OF CINCINNATI,OH,"$331,443"
Lung Cancer,2010,NCI,5R00CA126026-04,,Role of EGFR mutations and new therapeutics in lung cancer,"KOBAYASHI, SUSUMU",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$249,000"
Lung Cancer,2010,NCI,5R01CA061021-17,,Effect of Tobacco Advocacy at the State Level,"GLANTZ, STANTON",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$507,991"
Lung Cancer,2010,NCI,5K08CA131483-03,,TGFbeta and lung squamous cell carcinoma,"MALKOSKI, STEPHEN",UNIVERSITY OF COLORADO DENVER,CO,"$136,900"
Lung Cancer,2010,NCI,1R43CA150447-01,,Thorax Autosegmentation for Radiotherapy of Lung Cancer,"HOLLOWAY, RICHARD","MORPHORMICS, INC.",NC,"$150,000"
Lung Cancer,2010,NCCAM,5F31AT005041-02,,Redox Mechanisms of Chemoprevention in Lung by Selenium Supplementation,"POERSCHKE, ROBYN",UNIVERSITY OF UTAH,UT,"$29,188"
Lung Cancer,2010,NCCAM,7R01AT003203-04,,Chemoprevention of Lung Cancer with Anti-tumor B,"YOU, MING",MEDICAL COLLEGE OF WISCONSIN,WI,"$365,038"
Lung Cancer,2010,NCI,1F32CA150637-01,,The Molecular Basis for Erlotinib-Resistance in Lung Cancer with wild-type EGFR,"SATTERLY, NEAL",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$47,606"
Lung Cancer,2010,NCI,5U01CA114771-06,,Molecular Signatures of Lung Cancer,"CARBONE, DAVID",VANDERBILT UNIVERSITY,TN,"$1,594,760"
Lung Cancer,2010,NCI,5K07CA125203-03,,Exploring Common Linkage Regions in Lung Cancer and COPD,"COTE, MICHELE",WAYNE STATE UNIVERSITY,MI,"$132,921"
Lung Cancer,2010,NCI,5R21CA135608-02,,Phase I Trial with Two HER-2 B Cell Epitope Vaccine in Patients with Solid Tumors,"KAUMAYA, PRAVIN",OHIO STATE UNIVERSITY,OH,"$330,000"
Lung Cancer,2010,NCI,5K08CA137170-02,,Role of Bronchioalveolar Stem Cells in Tissue Repair and Lung Adenocarcinomas,"KUMAR, ATUL",STANFORD UNIVERSITY,CA,"$148,623"
Lung Cancer,2010,NCI,5K24CA128953-03,,Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer,"ANTONIA, SCOTT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$167,791"
Lung Cancer,2010,NCI,5U01CA084306-12,,Integrative genomic characterization of lung cancer metastasis in mouse and human,"JACKS, TYLER",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$790,696"
Lung Cancer,2010,NCI,5K99CA140792-02,,Mutant Epidermal Growth Factor Receptor Signaling in Lung Cancer,"GUHA, UDAYAN",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$165,780"
Lung Cancer,2010,NIBIB,5R37EB000244-31,,Controlled Release of Macromolecules,"LANGER, ROBERT",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$402,150"
Lung Cancer,2010,NIA,5F30AG030298-04,,The Contribution of Chronic Inflammation to Pulmonary Adenocarcinoma,"DOUGAN, MICHAEL",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$46,380"
Lung Cancer,2010,NCCAM,5R21AT004503-02,,Anti-carcinogenic effects of White Tea on Lung Cancer,"MAO, JENNY",BIOMEDICAL RESEARCH INSTITUTE OF NEW MEX,NM,"$136,873"
Lung Cancer,2010,NCI,5K01CA128887-02,,The Role of MicroRNAs in Controlling Fibroblast Proliferation and Tumor Promotion,"LEGESSE-MILLER, ASTER",PRINCETON UNIVERSITY,NJ,"$118,302"
Lung Cancer,2010,NCI,1U19CA148127-01,8822,Transdisciplinary Research in Cancer of the Lung- Discovery of Novel Variants,"AMOS, CHRISTOPHER",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$1,813,057"
Lung Cancer,2010,NCI,1U19CA148127-01,8823,Functional Studies of Candidate Lung Cancer Susceptibility Genes,"AMOS, CHRISTOPHER",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$400,948"
Lung Cancer,2010,NCI,1U19CA148127-01,8824,Epidemiologic Architedure of Lung Cancer and Smoking,"AMOS, CHRISTOPHER",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$292,402"
Lung Cancer,2010,NCI,1U19CA148127-01,8825,Administrative Core,"AMOS, CHRISTOPHER",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$312,497"
Lung Cancer,2010,NCI,5R01CA116648-05,,Validating Molecular Signature Risk Models of NSCLC,"HARPOLE, DAVID",DUKE UNIVERSITY,NC,$1
Lung Cancer,2010,NCI,5R01CA121922-04,,Young Smoker's Reactions to Genetic Risk for Lung Cancer,"LIPKUS, ISAAC",DUKE UNIVERSITY,NC,"$446,380"
Lung Cancer,2010,NCI,5R44CA121612-03,,New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells,"AUNG, SANDRA","UBIVAC, LLC",OR,"$685,832"
Lung Cancer,2010,NCCAM,7R01AT005522-02,,Chemoprevention of lung cancer with red ginseng extracts,"YOU, MING",MEDICAL COLLEGE OF WISCONSIN,WI,"$286,114"
Lung Cancer,2010,OD,7R01AT005522-02,,Chemoprevention of lung cancer with red ginseng extracts,"YOU, MING",MEDICAL COLLEGE OF WISCONSIN,WI,"$200,000"
Lung Cancer,2010,NIEHS,2P42ES004940-21,5084,Project 3: Pulmonary Response to Toxicants In Susceptible Population,"LANTZ, ROBERT",UNIVERSITY OF ARIZONA,AZ,"$175,898"
Lung Cancer,2010,NCI,5U01CA141550-02,,Preventive Interventions Leadership U01,"HANASH, SAMIR",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$412,163"
Lung Cancer,2010,NCI,5R01CA131217-02,,Nonpeptide macrocyclic histone deacetylase (HDAC) inhibitors for targeted lung ca,"OYELERE, ADEGBOYEGA",GEORGIA INSTITUTE OF TECHNOLOGY,GA,"$301,362"
Lung Cancer,2010,NCI,5K07CA138772-03,,Improving decisions about evaluating pulmonary nodules for lung cancer,"WIENER, RENDA",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$169,236"
Lung Cancer,2010,NCI,5R01CA138624-02,,Phase III Trial of Exercise Training in Postsurgical Lung Cancer,"JONES, LEE",DUKE UNIVERSITY,NC,"$417,275"
Lung Cancer,2010,NCI,5R01CA111703-05,,MOLECULAR EPIDEMIOLOGY OF LUNG CANCER,"CHEN, CHU",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$386,463"
Lung Cancer,2010,NCI,5R01CA127636-04,,Impact of BRG1 Loss in Lung Cancer Development,"REISMAN, DAVID",UNIVERSITY OF FLORIDA,FL,$1
Lung Cancer,2010,NCI,1R21CA151250-01,,Atypical PKC signaling in lung cancer stem cells,"FIELDS, ALAN",MAYO CLINIC  JACKSONVILLE,FL,"$168,563"
Lung Cancer,2010,NCI,5R03CA143999-02,,ISC-4 as a Novel Lung Cancer Chemopreventive Agent,"SHARMA, ARUN",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$76,317"
Lung Cancer,2010,NIDA,5R21DA026918-02,,Function of the CHRNA5 D398N SNP:  implications for addiction and lung cancer ris,"STITZEL, JERRY",UNIVERSITY OF COLORADO AT BOULDER,CO,"$449,136"
Lung Cancer,2010,NCI,5R01CA133539-02,,Radiotherapy with Dose-Rate Regulated Tracking,"YI, BYONGYONG",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$347,202"
Lung Cancer,2010,NINR,5F31NR011261-02,,A Study of Medication Taking for NSCLC Patients Receiving Oral Targeted Therapy,"WICKERSHAM, KAREN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$41,380"
Lung Cancer,2010,NCI,1R01CA152043-01,,Are Disparities in Cancer Chemotherapy Treatment Affected by Medicare Reimburseme,"JACOBSON, MIREILLE",RAND CORPORATION,CA,"$319,213"
Lung Cancer,2010,NCI,1R01CA151433-01,,Multimodal Image-Guided Intervention System for Lung-Cancer Diagnosis and Staging,"HIGGINS, WILLIAM",PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,PA,"$213,496"
Lung Cancer,2010,NCI,1R01CA152301-01,,Predicting Adjuvant Chemotherapy Response in Lung Cancer,"XIE, YANG",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$151,882"
Lung Cancer,2010,NCI,1R01CA152005-01,,An Integrated Nano-Cell Delivery Platform of Theranostics for Lung Cancers,"MOHAPATRA, SHYAM",UNIVERSITY OF SOUTH FLORIDA,FL,"$305,025"
Lung Cancer,2010,NCI,1K99CA151672-01,,Cancer gene discovery using Sleeping Beauty transposon-mediated mutagenesis,"STARR, TIMOTHY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$102,247"
Lung Cancer,2010,NCI,1K08CA151651-01,,MicroRNA-200 family regulation by the apical-basal polarity complexes in EMT and,"GIBBONS, DON",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$170,640"
Lung Cancer,2010,NCI,1K99CA151968-01,,Functional Characterization of Lung Adenocarcinoma Progression and Metastasis,"WINSLOW, MONTE",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$111,105"
Lung Cancer,2010,NCI,1U01CA151452-01,,COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE,"AMIJI, MANSOOR",NORTHEASTERN UNIVERSITY,MA,"$482,687"
Lung Cancer,2010,NCI,5F32CA142039-02,,Lung squamous cell carcinoma subtypes: genomic abberations and clinical detection,"WILKERSON, MATTHEW",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$52,016"
Lung Cancer,2010,NCI,1R01CA142724-01A1,,Role of Foxm1 in Lung Cancer Microenvironment,"KALIN, TANYA",CHILDREN'S HOSPITAL MED CTR (CINCINNATI),OH,"$316,438"
Lung Cancer,2010,NHLBI,1DP2OD007044-01,,Spatially Accurate Deformable Image Registration for Thoracic CT Application,"GUERRERO, THOMAS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$2,370,000"
Lung Cancer,2010,NCI,1R01CA136534-01A2,,Structure-based anti-cancer drug development,"DENG, XINGMING",EMORY UNIVERSITY,GA,"$319,563"
Lung Cancer,2010,NCI,1U01CA152662-01,,Validation of Biomarkers of Risk for the Early Detection of Lung Cancer,"MASSION, PIERRE",VANDERBILT UNIVERSITY,TN,"$632,571"
Lung Cancer,2010,NCI,2U01CA111295-04,,The North American Mesothelioma Consortium,"PASS, HARVEY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$608,087"
Lung Cancer,2010,NCI,2U01CA086137-11,,NYU Lung Cancer Biomarker Center,"ROM, WILLIAM",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$800,160"
Lung Cancer,2010,NCI,1U54CA151652-01,8811,Therapeutic Targeting of the Ras Pathway By Nanoparticle Delivery of siRNA,"HUANG, LEAF",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$160,409"
Lung Cancer,2010,NCI,1U54CA151652-01,8812,Translational Nanosystems for Improved Lung Cancer Treatment with Small Molecules,"MUMPER, RUSSELL",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$332,550"
Lung Cancer,2010,NCI,1U54CA151652-01,8816,Targeting Ligand Core,"LIU, RIHE",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$81,915"
Lung Cancer,2010,NCI,2U24CA115091-06,,"University of Maryland, Baltimore Biomarker Reference Laboratory","STASS, SANFORD",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$382,500"
Lung Cancer,2010,NCI,1U01CA152751-01,,The UCLA - Boston University Lung Cancer Biomarker Development Laboratory,"DUBINETT, STEVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$725,083"
Lung Cancer,2010,NCI,1U54CA151459-01,8856,Magneto-Nano Diagnostic and Analytical Devices for Cancer,"WANG, SHAN",STANFORD UNIVERSITY,CA,"$292,060"
Lung Cancer,2010,NCI,1U54CA151459-01,8857,Nanotechnologies for Comprehensive Single Cancer Cell Analysis,"QUAKE, STEPHEN",STANFORD UNIVERSITY,CA,"$586,855"
Lung Cancer,2010,NCI,1U54CA151459-01,8858,Integration of Nano-Molecular Imaging and Nanosensors,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$193,500"
Lung Cancer,2010,NCI,2U01CA084986-11,,Integrated Development of Novel Molecular Markers,"SIDRANSKY, DAVID",JOHNS HOPKINS UNIVERSITY,MD,"$393,600"
Lung Cancer,2010,NCI,1U54CA151838-01,5102,Mucus Penetrating Nanoparticles for Small Cell Lung Cancer,"HANES, JUSTIN",JOHNS HOPKINS UNIVERSITY,MD,"$214,864"
Lung Cancer,2010,OD,1R01CA142649-01A1,,Developing a Post-carcinogen Lung Cancer Chemopreventive Agent,"XING, CHENGGUO",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$200,000"
Lung Cancer,2010,NCI,1U54CA151881-01,5126,Develop and High-Throughput Screening of Targeted Anticancer Nanomedicines,"PETRENKO, VALERY",AUBURN UNIVERSITY,AL,"$327,201"
Lung Cancer,2010,NCI,1R01CA138528-01A1,,Role of the noncanonical WNT pathway in non-small cell lung cancer,"WINN, ROBERT",UNIVERSITY OF COLORADO DENVER,CO,"$309,557"
Lung Cancer,2010,NCI,1U01CA152956-01,,Comparative Modeling of Lung Cancer Control Policies,"MCMAHON, PAMELA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$1,187,774"
Lung Cancer,2010,NHLBI,1R01HL098686-01A1,,Model-Based Image Reconstruction for X-ray CT in Lung Imaging,"FESSLER, JEFFREY",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$622,695"
Lung Cancer,2010,NCI,1R01CA144053-01A1,,Chemopreventive effect of fish oil derived EPA in lung cancer,"YANG, PEIYING",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$327,850"
Lung Cancer,2010,NIEHS,1R01ES017328-01A2,,Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1,"LIN, YONG",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$456,076"
Lung Cancer,2010,NIEHS,1R01ES018883-01A1,,HIF-alphia in Cr(VI) carcinogenesis,"ZHANG, ZHUO",UNIVERSITY OF KENTUCKY,KY,"$334,125"
Lung Cancer,2010,NCI,1R01CA143111-01A1,,Screening Lung Cancer by Ultra Low-Dose Computed Tomography,"LIANG, JEROME",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$323,794"
Lung Cancer,2010,NCI,1R01CA140654-01A1,,The Role of Cul4A in Genome Stability and Cancer Development,"YOU, LIANG",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$313,751"
Lung Cancer,2010,NCI,2R01CA120247-05,,Mutant EGF Receptor-Dependent Lung Cancer in Human Cell Lines and Transgenic Mice,"POLITI, KATERINA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$383,570"
Lung Cancer,2010,NINDS,1K08NS065268-01A1,,Optimizing EGFR Targeted Therapy in Malignant Glioma,"NICOLAIDES, THEODORE",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$158,136"
Lung Cancer,2010,NIEHS,1R21ES017334-01A1,,Mechanisms of particulate chromium lung carcinogenesis,"CERYAK, SUSAN",GEORGE WASHINGTON UNIVERSITY,DC,"$234,750"
Lung Cancer,2010,NCI,2P50CA114747-06,5347,Monitoring Response to Targeted Therapy in Non-Small Cell Lung Cancer Using 18F..,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$892,981"
Lung Cancer,2010,NCI,2P50CA114747-06,5349,Multi-Modality Imaging of Oncogene Addiction,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$147,124"
Lung Cancer,2010,NCI,1R21CA135240-01A2,,Glycomic Markers of Non-Small Cell Lung Cancer,"MIYAMOTO, SUZANNE",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$166,388"
Lung Cancer,2010,NCI,1R21CA139371-01A2,,Development of a Conjoint Analysis Instrument for Lung Cancer Screening Decisions,"BYRNE, MARGARET",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$219,583"
Lung Cancer,2010,NCI,1R01CA148565-01A1,,PET Imaging of KRAS2 Activation to Guide EGFR Targeting in Cancer Therapy,"WICKSTROM, ERIC",THOMAS JEFFERSON UNIVERSITY,PA,"$623,627"
Lung Cancer,2010,NCI,1R01CA143597-01A1,,Serum Levels of EGFR-Signaling-Network Activators/Inhibitor and Lung Cancer Risk,"HO, GLORIA",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$702,820"
Lung Cancer,2010,NCI,1R21CA153268-01,,Wnt 7a and Its Role in EMT and Lung Cancer Metastasis,"WINN, ROBERT",UNIVERSITY OF COLORADO DENVER,CO,"$191,365"
Lung Cancer,2010,NCI,1R43CA153842-01,,U1 Adaptor:Dendrimer silencing of BCL2 for tumor suppression.,"GORACZNIAK, RAFAL","SILAGENE, INC.",NJ,"$189,496"
Lung Cancer,2010,NCI,2R42CA120616-02,,Development of a Perfusion-induced Systemic Hyperthermia Delivery Apparatus,"ZWISCHENBERGER, JOSEPH","MC3, INC.",MI,"$685,117"
Lung Cancer,2010,NIEHS,1F30ES019464-01,,Suppression of Lung Cancer Growth by Ceramide,"SADDOUGHI, SAHAR",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$39,025"
Lung Cancer,2010,NCI,1F32CA153736-01,,Identification of Nrf2 DNA binding Co-Factors involved in regulation of gene expr,"HAPPEL, CHRISTINE",JOHNS HOPKINS UNIVERSITY,MD,"$48,086"
Lung Cancer,2010,NCI,1F32CA153885-01,,Therapeutic use of let-7 and miR-34 microRNAs for the prevention and treatment of,"KASINSKI, ANDREA",YALE UNIVERSITY,CT,"$47,606"
Lung Cancer,2010,NCI,1F32CA154237-01,,Lung cancer initiating cells in a tumor mouse model deficient in Cdkn2ab,"SCHUSTER, KATJA",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$52,154"
Lung Cancer,2010,NCI,1R21CA144190-01A1,,DCE-MRI for Assessment of Vascular Normalization by Nelfinavir in Lung Cancer,"RENGAN, RAMESH",UNIVERSITY OF PENNSYLVANIA,PA,"$329,510"
Lung Cancer,2010,NCI,1R03CA154016-01,,Conceptualization and Measurement of Lung Cancer Stigma,"HAMANN, HEIDI",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$79,250"
Lung Cancer,2010,NCI,1R03CA154056-01,,Psychological Symptoms and High-Quality Cancer Care in Patients with Lung Cancer,"LENNES, INGA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$88,500"
Lung Cancer,2010,NCI,5P30CA016042-35,5636,Thoracic Oncology,"DUBINETT, STEVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$44,796"
Lung Cancer,2010,RMAP,1R03MH092170-01,,Discovering Nrf2 inhibitors to enhance cancer chemotherapy and radiotherapy,"BISWAL, SHYAM",JOHNS HOPKINS UNIVERSITY,MD,"$41,000"
Lung Cancer,2010,NCI,1R21CA154319-01,,Stratifying the progression and prognosis of lung cancer subtypes with tumor supp,"SHENG, SHIJIE",WAYNE STATE UNIVERSITY,MI,"$165,300"
Lung Cancer,2010,NCI,5P50CA058184-15,8042,P1:  Epigenetic Staging and Therapy for Lung Cancers,"HERMAN, JAMES",JOHNS HOPKINS UNIVERSITY,MD,"$279,934"
Lung Cancer,2010,NCI,5P50CA058184-15,8044,P2:  Gene Promoter Hypermethylation as a Biomarker for Lung Cancer Detection,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$517,485"
Lung Cancer,2010,NCI,5P50CA058184-15,8045,P3:  Deregulated NRF2-KEAP1 Pathway as a Critical Regulator of Chemoresistance,"BISWAL, SHYAM",JOHNS HOPKINS UNIVERSITY,MD,"$241,947"
Lung Cancer,2010,NCI,5P50CA058184-15,8046,P4:  Inhibition of Fatty Acid Synthase for Lung Cancer Treatment,"GABRIELSON, EDWARD",JOHNS HOPKINS UNIVERSITY,MD,"$148,146"
Lung Cancer,2010,NCI,5P50CA058184-15,8049,CA:  Administrative Core,"BAYLIN, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$99,861"
Lung Cancer,2010,NCI,5P50CA058184-15,8050,CB:  Human Tissue and Pathology,"GABRIELSON, EDWARD",JOHNS HOPKINS UNIVERSITY,MD,"$245,983"
Lung Cancer,2010,NCI,5P50CA058184-15,8052,CC:  Statistical Core,"GOODMAN, STEVEN",JOHNS HOPKINS UNIVERSITY,MD,"$102,355"
Lung Cancer,2010,NCI,5P50CA058184-15,8054,Development Research Program,"BAYLIN, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$249,648"
Lung Cancer,2010,NCI,5P50CA058184-15,8058,Career Development Program,"BAYLIN, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$86,131"
Lung Cancer,2010,NCI,2R44CA123994-04,,PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm,"LEBOWITZ, MICHAEL","20/20 GENESYSTEMS, INC.",MD,"$750,000"
Lung Cancer,2010,NCI,5P30CA077598-12,5746,Carcinogenesis & Chemoprevention,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$30,006"
Lung Cancer,2010,NCI,3U01CA086137-10S1,,NYU Lung Cancer Biomarker Center,"ROM, WILLIAM",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$172,938"
Lung Cancer,2010,NCI,3U24CA115091-05S1,,University of Maryland Biomarker Reference Laboratory,"STASS, STANFORD",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$137,000"
Lung Cancer,2010,NIEHS,5P42ES013660-06,6031,Project 4: Biological Dosimetry of Hexavalent Chromium,"ZHITKOVICH, ANATOLY",BROWN UNIVERSITY,RI,"$271,505"
Lung Cancer,2010,NCI,5P01CA087971-08,0005,Enhancing Direct Tumor Cell Cytotoxicity By Manipulating Growth Factor Signaling,"HAHN, STEPHEN",UNIVERSITY OF PENNSYLVANIA,PA,"$202,364"
Lung Cancer,2010,NCI,5P01CA087971-08,0008,PDT for NSCLC with pleural carcinomatosis,"FRIEDBERG, JOSEPH",UNIVERSITY OF PENNSYLVANIA,PA,"$158,008"
Lung Cancer,2010,NCI,5P01CA087971-08,9003,Biostatistics and Data Coordinating Core (BDCC),"PUTT, MARY",UNIVERSITY OF PENNSYLVANIA,PA,"$162,288"
Lung Cancer,2010,NCI,1F31CA157150-01,,Fhit as modulator of Chk1 termination and response to DNA-damaging agents,"SALDIVAR, JOSHUA",OHIO STATE UNIVERSITY,OH,"$28,320"
Lung Cancer,2010,NIEHS,5P42ES004705-23,0016,Project 3: Arsenic Biomarker Epidemiology,"SMITH, ALLAN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$419,658"
Lung Cancer,2010,NCI,3R01CA121144-02S1,,Chemoresistance and Motility: Role of Mutant p53 and NF-kB2 in Cancer,"DEB, SUMITRA",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$30,000"
Lung Cancer,2010,NCI,261200900046C-2-0-1,,SBIR PROPOSAL FOR PHS 2009-1 TOPIC 266 FOR A TARGETED NANOCOMPLIX FOR EARLY DETE,"BAWA, RAJ","SYNERGENE THERAPEUTICS, INC.",DC,"$498,331"
Lung Cancer,2010,NCI,1U54CA156734-01,5415,Racial Disparities in Depression and Mental Healthcare Utilization in Lung Cancer,"CANNON, SHEILA",UNIVERSITY OF MASSACHUSETTS BOSTON,MA,"$15,637"
Lung Cancer,2010,NCI,1U54CA156732-01,5439,Racial Disparities in Depression and Mental Healthcare Utilization in Lung Cancer,"CANNON, SHEILA",UNIVERSITY OF MASSACHUSETTS BOSTON,MA,"$72,365"
Lung Cancer,2010,NIEHS,5P42ES010349-10,0003,Project 2: Health Effects of As Cohort Study,"AHSAN, HABIBUL",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$304,732"
Lung Cancer,2010,NCI,5P30CA046934-23,0010,TOBACCO RELATED MALIGNANCIES,"MILLER, YORK",UNIVERSITY OF COLORADO DENVER,CO,"$24,736"
Lung Cancer,2010,NCI,N1CN25476A-83-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","O'BRIEN, BARBARA","WESTAT, INC.",MD,"$3,277,040"
Lung Cancer,2010,NCI,N1CN25476A-83-0-2,,National Lung Screening Trial,"O'BRIEN, BARBARA","WESTAT, INC.",MD,"$2,681,213"
Lung Cancer,2010,NCI,7R01CA115707-05,,Targeting Notch3 in Lung Cancer,"DANG, THAO",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$263,088"
Lung Cancer,2010,NCI,5P01CA116602-04,0004,Four-dimensional Adaptive Thoracic Radiotherapy,"KEALL, PAUL",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$315,961"
Lung Cancer,2010,NCI,4R44CA139803-02,,Field of Injury Based Biomarkers for Lung Cancer,"HALLAM, STEPHANIE","ALLEGRO DIAGNOSTICS, INC.",MA,"$1,823,081"
Lung Cancer,2010,NCI,4R00CA131477-03,,UDP-glucuronosyltransferase genes and gender-differences in lung cancer risk,"GALLAGHER, CARLA",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$246,669"
Lung Cancer,2010,NCI,5P30CA138292-02,5750,PROGRAM LEADERS,"DOETSCH, PAUL",EMORY UNIVERSITY,GA,"$251,549"
Lung Cancer,2010,NCI,5P50CA090440-10,0006,P1 - Intersection of Estrogen Receptor Signaling and EGF Receptor,"SIEGFRIED, JILL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$274,725"
Lung Cancer,2010,NCI,5P50CA090440-10,0007,"P2 - CYCLIN B1 IN IMMUNOTHERAPY, DIAGNOSIS, AND PROGNOSIS OF LUNG CANCER","FINN, OLIVERA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$318,563"
Lung Cancer,2010,NCI,5P50CA090440-10,0008,P3 - SERUM PROTEOMIC BIOMARKERS FOR LUNG CANCER DETECTION AND PROGNOSIS,"BIGBEE, WILLIAM",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$239,739"
Lung Cancer,2010,NCI,5P50CA090440-10,0009,P4 - NUCLEOTIDE EXCISION REPAIR/CELL CYCLE CONTROL HAPLOTYES AND LC RISK,"ROMKES, MARJORIE",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$318,828"
Lung Cancer,2010,NCI,5P50CA090440-10,0010,DEVELOPMENTAL RESEARCH PROGRAM,"BIGBEE, WILLIAM",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$108,778"
Lung Cancer,2010,NCI,5P50CA090440-10,0011,CAREER DEVELOPMENT PROGRAM,"GREENBERGER, JOEL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$108,778"
Lung Cancer,2010,NCI,5P50CA090440-10,9001,TISSUE AND BLOOD BANK CORE,"DHIR, RAKIV",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$183,089"
Lung Cancer,2010,NCI,5P50CA090440-10,9003,BIOSTATISTICS/BIOINFORMATICS CORE,"LAND, STEPHANIE",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$87,385"
Lung Cancer,2010,NCI,5P50CA090440-10,9004,CLINICAL CORE,"WEISSFIELD, JOEL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$516,402"
Lung Cancer,2010,NCI,4R00CA131488-03,,Mechanisms of Mutant Epidermal Growth Factor Receptor Induced Lung Tumorigenesis,"POLITI, KATERINA",YALE UNIVERSITY,CT,"$249,000"
Lung Cancer,2010,NCI,3R01CA132608-03S1,,Inflammation in Oncogenic K-ras-induced Lung Tumorigenesis,"KURIE, JONATHAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$62,402"
Lung Cancer,2010,NCI,5P01CA059827-15,0009,INDIVIDUALIZED DOSE ESCALATION IN VOLUME-EFFECT ORGANS,"LAWRENCE, THEODORE",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$408,009"
Lung Cancer,2010,NCI,N02CN63300-5-0-2,,Computer Support for Lung Cancer Screening in the PLCO Cancer Screening Trial,"LAKE, WILLIAM","INFORMATION MANAGEMENT SERVICES, INC.",MD,"$1,020,434"
Lung Cancer,2010,NIMHD,5P20MD003352-03,0001,The Effect of Isothiocyanate Consumption on NNAL Metabolism in Smokers,"HULL, ANNA",LINCOLN UNIVERSITY,PA,"$394,193"
Lung Cancer,2010,NCI,5P50CA090578-08,0011,Developmental Research Program,"JOHNSON, BRUCE",DANA-FARBER CANCER INSTITUTE,MA,"$139,950"
Lung Cancer,2010,NCI,5P50CA090578-08,0012,Career Development Program,"CHRISTIANI, DAVID",DANA-FARBER CANCER INSTITUTE,MA,"$139,950"
Lung Cancer,2010,NCI,5P50CA090578-08,9001,CA: Tissue and Pathology,"LODA, MASSIMO",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$693,759"
Lung Cancer,2010,NCI,5P50CA090578-08,9002,CC: Biostatistics,"YEAP, BEOW",MASSACHUSETTS GENERAL HOSPITAL,MA,"$373,019"
Lung Cancer,2010,NCI,5P50CA090578-08,9004,"CB: Administration, Evaluation, and Planning","JOHNSON, BRUCE",DANA-FARBER CANCER INSTITUTE,MA,"$629,237"
Lung Cancer,2010,NCI,5P50CA090578-08,9005,CD: Genomics and Bioinformatics,"MEYERSON, MATTHEW",DANA-FARBER CANCER INSTITUTE,MA,"$324,085"
Lung Cancer,2010,NHLBI,5P01HL091842-03,9003,Imaging Core,"MCLENNAN, GEOFFREY",UNIVERSITY OF IOWA,IA,"$157,128"
Lung Cancer,2010,NCI,5P50CA058187-16,0018,SEMA3F and ZEB1 in Lung Cancer: Therapy and Target Gene Discovery,"DRABKIN, HARRY",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$380,544"
Lung Cancer,2010,NCI,5P50CA058187-16,0019,Growth Factor Inhibitors for Lung Cancer Therapy and Prevention,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$279,306"
Lung Cancer,2010,NCI,5P50CA058187-16,0020,Prostacyclin and Peroxisome Proliferator- Activated Receptor Gamma in Lung Cancer,"NEMENOFF, RAPHAEL",UNIVERSITY OF COLORADO DENVER,CO,"$279,316"
Lung Cancer,2010,NCI,5P50CA058187-16,0021,The Biology of Pulmonary Premalignancy: Application to Risk Assessment and Chemop,"MILLER, YORK",UNIVERSITY OF COLORADO DENVER,CO,"$264,631"
Lung Cancer,2010,NCI,5P50CA058187-16,0022,Developmental Research Program,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$62,613"
Lung Cancer,2010,NCI,5P50CA058187-16,0023,Career Development Program,"MILLER, YORK",UNIVERSITY OF COLORADO DENVER,CO,"$62,613"
Lung Cancer,2010,NCI,5P50CA058187-16,9001,Tissue Bank and Biomarkers Core,"FRANKLIN, WILBUR",UNIVERSITY OF COLORADO DENVER,CO,"$315,630"
Lung Cancer,2010,NCI,5P50CA058187-16,9002,Clinical Trials Core,"KEITH, ROBERT",UNIVERSITY OF COLORADO DENVER,CO,"$266,846"
Lung Cancer,2010,NCI,5P50CA058187-16,9003,Biostatistics and Informatics Core,"BARON, ANNA",UNIVERSITY OF COLORADO DENVER,CO,"$252,423"
Lung Cancer,2010,NCI,5P50CA058187-16,9006,Administration Core,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$136,078"
Lung Cancer,2010,NCI,5P50CA119997-03,0001,P1 - E2F's impact on Therapeutic Efficacy,"CRESS, DOUG",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$316,733"
Lung Cancer,2010,NCI,5P50CA119997-03,0002,P3 - Antitumor Mechanisms of SRC Inhibitors in Lung Cancer,"HAURA, ERIC",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$367,877"
Lung Cancer,2010,NCI,5P50CA119997-03,0003,P4 - Lung Cancer Chemoprevention with Enzastaurin,"BEPLER, GEROLD",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$374,480"
Lung Cancer,2010,NCI,5P50CA119997-03,0004,P5 - P-53-Based Vaccine for Small Cell Lung Cancer,"GABRILOVICH, DMITRY",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$363,048"
Lung Cancer,2010,NCI,5P50CA119997-03,0006,CDP - Career Development Program,"HAURA, ERIC",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$96,496"
Lung Cancer,2010,NCI,5P50CA119997-03,9001,"CA: Tissue Procurement, Pathology, and Biomedical Informatics","ALTOIK, SONER",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$216,998"
Lung Cancer,2010,NCI,5P50CA119997-03,9002,CB: Clinical Trials and Biostatistics Core,"SIMON, GEORGE",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$362,868"
Lung Cancer,2010,NCI,5P50CA119997-03,9003,CC: Administration and Patient Advocacy,"BEPLER, GEROLD",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$218,717"
Lung Cancer,2010,NCI,5P50CA070907-13,0009,P-1: Molecular Signatures for Individualizing Lung Cancer Therapy,"MINNA, JOHN",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$261,165"
Lung Cancer,2010,NCI,5P50CA070907-13,0010,P-2: Risk Prediction of platinum-based chemotherapy and Radiotherapy Outcome,"WU, XIFENG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$355,249"
Lung Cancer,2010,NCI,5P50CA070907-13,0011,P-3: Targeting Tumor Microenvironment in NSCLC,"KURIE, JONATHAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$251,126"
Lung Cancer,2010,NCI,5P50CA070907-13,0012,P-4: Therapeutic Targeting of Telomerase and Lung Cancer,"SHAY, JERRY",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$184,090"
Lung Cancer,2010,NCI,5P50CA070907-13,0013,P-5: Translation of the 3p21.3 Gene FUS1 into Pathway-Targeted Molecular Therapy,"ROTH, JACK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$280,501"
Lung Cancer,2010,NCI,5P50CA070907-13,0014,Developmental Research Program,"ROTH, JACK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$70,831"
Lung Cancer,2010,NCI,5P50CA070907-13,9004,CB: Tissue Resources and Molecular Pathology,"WISTUBA, IGNACIO",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$258,862"
Lung Cancer,2010,NCI,5P50CA070907-13,9005,CA: Administration Core,"MINNA, JOHN",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$219,213"
Lung Cancer,2010,NCI,5P50CA070907-13,9006,CC: Biostatistics Core,"COOMBES, KEVIN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$238,105"
Lung Cancer,2010,NCI,5P50CA070907-13,9007,CD: Bioinformatics Core,"GARNER, HAROLD",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$110,027"
Lung Cancer,2010,NCI,5P50CA070907-13,9008,Career Development Program,"ROTH, JACK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$70,831"
Lung Cancer,2010,NCI,5P01CA116676-05,0001,Modulation of the mTOR Pathway for Lung Cancer Treatment,"KHURI, FADLO",EMORY UNIVERSITY,GA,"$385,887"
Lung Cancer,2010,NCI,5P01CA116676-05,0002,Altered LKB1/AMPK Signaling and Chemosensitivity in NSCLC,"ZHOU, WEI",EMORY UNIVERSITY,GA,"$247,987"
Lung Cancer,2010,NCI,5P01CA116676-05,0003,Targeting Microtubules and HDAC6 in NSCLC,"GIANNAKAKOU, PARASKEVI",EMORY UNIVERSITY,GA,"$407,769"
Lung Cancer,2010,NCI,5P01CA116676-05,0004,Targeting 14-3-3-Mediated Survival,"FU, HAIAN",EMORY UNIVERSITY,GA,"$312,133"
Lung Cancer,2010,NCI,5P01CA116676-05,9001,Pathology and Molecular Analysis,"GAL, ANTHONY",EMORY UNIVERSITY,GA,"$196,967"
Lung Cancer,2010,NCI,5P01CA116676-05,9002,Biostatistics,"ROGATKO, ANDRE",EMORY UNIVERSITY,GA,"$149,041"
Lung Cancer,2010,NCI,3R01CA119029-05S1,,Development of DNA Methylation Markers for Early Detection of Lung Cancer,"LAIRD-OFFRINGA, ITE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$52,213"
Lung Cancer,2010,NCI,5P01CA129243-04,0001,Brain-Specific Metastasis Genes,"MASSAGUE, JOAN",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$365,421"
Lung Cancer,2010,NCI,5P01CA129243-04,0002,KRAS- and BRAF- Driven Lung Adenocarcinoma,"ROSEN, NEAL",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$358,744"
Lung Cancer,2010,NCI,5P01CA129243-04,0003,EGFR Kinase Inhibitor-Persistent EGFR-Mutant Lung Adenocarcinoma,"PAO, WILLIAM",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$225,235"
Lung Cancer,2010,NCI,5P01CA129243-04,0004,Targeting EGFR and KRAS Mutations,"VARMUS, HAROLD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$392,439"
Lung Cancer,2010,NCI,5P01CA129243-04,9001,Molecular Profiling and Pathology,"LADANYI, MARC",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$365,233"
Lung Cancer,2010,NCI,5P01CA129243-04,9002,Information Engineering,"LASH, ALEX",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$178,590"
Lung Cancer,2010,NCI,3R01CA131348-03S1,,Prognosis and Effectiveness of Advanced Lung Cancer Treatment in the Elderly,"WISNIVESKY, JUAN",MOUNT SINAI SCHOOL OF MEDICINE,NY,"$94,778"
Lung Cancer,2010,NCI,4R00CA134920-03,,Optical Imaging of the Pulmonary Airways in the Assessment of Lung Cancer,"SUTER, MELISSA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$248,998"
Lung Cancer,2010,RMAP,2PN2EY018228-06,,The Center for Systemic Control of Cyto-Networks,"HO, CHIH-MING",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$1,230,000"
Lung Cancer,2010,NCI,5P01CA066726-14,0004,Clinical Trials in Mesothelioma,"STERMAN, DANIEL",UNIVERSITY OF PENNSYLVANIA,PA,"$428,952"
Lung Cancer,2010,NCI,5P01CA066726-14,0006,Immunogene Ther. of Mesothelin Express. Tumors Using Lentiviral Engineered TCells,"JUNE, CARL",UNIVERSITY OF PENNSYLVANIA,PA,"$179,855"
Lung Cancer,2010,NCI,5P30CA082103-12,0011,TOBACCO CONTROL PROGRAM,"BENOWITZ, NEAL",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$70,560"
Lung Cancer,2010,NCI,5P01CA114047-05,0001,GENE ENVIRONMENT INTERACTIONS IN MESOTHELIOMA,"CARBONE, MICHELE",UNIVERSITY OF HAWAII AT MANOA,HI,"$437,829"
Lung Cancer,2010,NCI,5P01CA114047-05,0002,ERK PATHWAYS IN PATHOGENESIS OF MESOTHELIOMA,"MOSSMAN, BROOKE",UNIVERSITY OF VERMONT & ST AGRIC COLLEGE,VT,"$334,744"
Lung Cancer,2010,NCI,5P01CA114047-05,0003,AKT AND TUMOR SUPPRESSOR PATHWAYS IN MESOTHELIOMA,"TESTA, JOSEPH",FOX CHASE CANCER CENTER,PA,"$385,739"
Lung Cancer,2010,NCI,5P01CA114047-05,9001,CLINICAL CORE,"PASS, HARVEY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$115,716"
Lung Cancer,2010,NCI,5P01CA114047-05,9002,"PATHOLOGY, VIROLOGY, AND ANIMAL CORE","CARBONE, MICHELE",UNIVERSITY OF HAWAII AT MANOA,HI,"$284,324"
Lung Cancer,2010,NCI,5P01CA042063-25,0012,Investigaton of Small Regulatory RNAs in Tumor Development,"JACKS, TYLER",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$408,821"
Lung Cancer,2010,NCI,7R03CA137819-03,,ROLE OF AP-1 IN THE CHEMOPREVENTIVE FUNCTION OF GREEN TEA IN VIVO,"TICHELAAR, JAY",MEDICAL COLLEGE OF WISCONSIN,WI,"$61,200"
Lung Cancer,2010,NCI,7R01CA113793-06,,Chemoprevention with mTOR & Farnesyltransferase Inhibitors,"YOU, MING",MEDICAL COLLEGE OF WISCONSIN,WI,"$44,644"
Lung Cancer,2010,NCI,5P50CA090949-09,0001,CROSS CULTURAL STUDY OF LUNG CANCER RISK AND INFLAMMATORY PATHWAY SNPS,"CAI, QIUYIN",VANDERBILT UNIVERSITY,TN,"$323,905"
Lung Cancer,2010,NCI,5P50CA090949-09,0002,MOLECULAR SIGNATURES OF NSCLC,"MASSION, PIERRE",VANDERBILT UNIVERSITY,TN,"$379,941"
Lung Cancer,2010,NCI,5P50CA090949-09,0003,EICOSANOID PATHWAY TARGETS IN LUNG CANCER,"JOHNSON, DAVID",VANDERBILT UNIVERSITY,TN,"$219,591"
Lung Cancer,2010,NCI,5P50CA090949-09,0004,TARGETING NOTCH 3 IN LUNG CANCER,"DANG, THAO",VANDERBILT UNIVERSITY,TN,"$212,862"
Lung Cancer,2010,NCI,5P50CA090949-09,0005,TARGETING HISTONE DEACETYLASES IN NSCLC,"DATTA, PRAN",VANDERBILT UNIVERSITY,TN,"$230,427"
Lung Cancer,2010,NCI,5P50CA090949-09,0006,DEVELOPMENTAL RESEARCH PROGRAM,"CARBONE, DAVID",VANDERBILT UNIVERSITY,TN,"$68,578"
Lung Cancer,2010,NCI,5P50CA090949-09,0007,CAREER DEVELOPMENT PROGRAM,"CARBONE, DAVID",VANDERBILT UNIVERSITY,TN,"$205,703"
Lung Cancer,2010,NCI,5P50CA090949-09,9001,PATHOLOGY AND TISSUE RESOURCES CORE,"GONZALEZ, ADRIANA",VANDERBILT UNIVERSITY,TN,"$336,293"
Lung Cancer,2010,NCI,5P50CA090949-09,9002,CLINICAL CORE,"SANDLER, ALAN",VANDERBILT UNIVERSITY,TN,"$116,809"
Lung Cancer,2010,NCI,5P50CA090949-09,9003,BIOSTATISTICS CORE,"SHYR, YU",VANDERBILT UNIVERSITY,TN,"$205,891"
Lung Cancer,2010,NCI,5P50CA095817-08,0005,ICCS in Lung Cancer: Evaluating Survival Benefits,"CLEARY, JAMES",UNIVERSITY OF WISCONSIN MADISON,WI,"$385,875"
Lung Cancer,2010,NCI,3R21CA151250-01S1,,Atypical PKC signaling in lung cancer stem cells,"FIELDS, ALAN",MAYO CLINIC  JACKSONVILLE,FL,"$80,341"
Lung Cancer,2010,NCI,5P01CA021239-31,0007,Proton Dose Escalation and Proton vs. Photon Randomized Trials,"KOMAKI, RITSUKO",MASSACHUSETTS GENERAL HOSPITAL,MA,"$403,629"
Lung Cancer,2010,NCI,N1CN25522A-98-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","ISAACS, CLAUDINE",GEORGETOWN UNIVERSITY,DC,"$906,613"
Lung Cancer,2010,NCI,N1CN25522A-98-0-2,,National Lung Screening Trial (NLST),"ISAACS, CLAUDINE",GEORGETOWN UNIVERSITY,DC,"$604,409"
Lung Cancer,2010,NCI,N1CN25515A-91-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","YOKOCHI, LANCE",PACIFIC HEALTH RESEARCH/ EDUCATION INST,HI,"$1,250,136"
Lung Cancer,2010,NCI,N1CN25515A-91-0-2,,National Lung Study Trial,"YOKOCHI, LANCE",PACIFIC HEALTH RESEARCH/ EDUCATION INST,HI,"$1,250,135"
Lung Cancer,2010,NCI,N1CN75022A-66-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","FOUAD, MONA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$516,583"
Lung Cancer,2010,NCI,N1CN75022A-66-0-2,,National Lung Screening Trial,"FOUAD, MONA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$774,876"
Lung Cancer,2010,NCI,N1CN25524A-81-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","BUYS, SAUNDRA",UNIVERSITY OF UTAH,UT,"$1,146,945"
Lung Cancer,2010,NCI,N1CN25518A-95-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","REDING, DOUGLAS",MARSHFIELD CLINIC RESEARCH FOUNDATION,WI,"$691,713"
Lung Cancer,2010,NCI,N1CN25518A-95-0-2,,National Lung Study Trial,"REDING, DOUGLAS",MARSHFIELD CLINIC RESEARCH FOUNDATION,WI,"$172,928"
Lung Cancer,2010,NCI,N1CN25514A-86-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,UNIVERSITY OF COLORADO DENVER,CO,"$938,510"
Lung Cancer,2010,NCI,N1CN25514A-86-0-2,,National Lung Screening Trial (NLST),NO PI IDENTIFIED,UNIVERSITY OF COLORADO DENVER,CO,"$625,673"
Lung Cancer,2010,NCI,N1CN25513A-96-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","CHURCH, TIMOTHY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$1,651,264"
Lung Cancer,2010,NCI,N1CN25513A-96-0-2,,National Lung Screening Trial (NLST),"CHURCH, TIMOTHY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$1,100,842"
Lung Cancer,2010,NCI,N1CN25511A-91-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","WEISSFELD, JOEL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$949,175"
Lung Cancer,2010,OD,3R21CA138277-03S1,,Ginger Extract: Bioavailability Study and Lung Cancer Preventive Effect,"SANG, SHENGMIN",NORTH CAROLINA AGRI & TECH ST UNIV,NC,"$126,000"
Lung Cancer,2010,NIA,1ZIAAG000982-01,,Chemokine Enhancement of Radiation Therapy,"ERSHLER, WILLIAM",NIH,,"$409,128"
Lung Cancer,2010,NIEHS,1ZIAES046008-20,,Genetic Susceptibility To Carcinogens and Toxicants,"BELL, DOUGLAS",NIH,,"$456,715"
Lung Cancer,2010,NIEHS,1ZIAES101574-08,,Genetic and environmental factors in cancer,"LONDON, STEPHANIE",NIH,,"$65,324"
Lung Cancer,2010,NCI,N1CN25512A-111-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","KVALE, PAUL",HENRY FORD HEALTH SYSTEM,MI,"$1,192,204"
Lung Cancer,2010,NCI,N1CN25512A-111-0-2,,National Lung Screening Trial (NLST),"KVALE, PAUL",HENRY FORD HEALTH SYSTEM,MI,"$641,956"
Lung Cancer,2010,NCI,1ZIABC005399-27,,Mechanistic Targeting of Lung Cancer,"ANDERSON, LUCY",NIH,,"$708,799"
Lung Cancer,2010,NCI,1ZIABC005480-25,,Molecular Epidemiology of Human Lung Cancer,"HARRIS, CURTIS",NIH,,"$793,889"
Lung Cancer,2010,NCI,1ZIABC005488-25,,Mechanisms of Inorganic Carcinogenesis,"WAALKES, MICHAEL",NIH,,"$828,727"
Lung Cancer,2010,NCI,1ZIABC009003-28,,The Role of Cripto in the Pathogenesis of Breast and Colon Cancer,"SALOMON, DAVID",NIH,,"$1,315,221"
Lung Cancer,2010,NCI,1ZIABC010033-15,,Inflammation and  Cancer,"HARRIS, CURTIS",NIH,,"$740,964"
Lung Cancer,2010,NCI,1ZIABC010620-07,,Clinical Studies to Circumvent Drug Resistance,"BATES, SUSAN",NIH,,"$136,330"
Lung Cancer,2010,NCI,1ZIABC010748-05,,Clinical Investigation of Signal Transduction Inhibitors,"DENNIS, PHILLIP",NIH,,"$584,706"
Lung Cancer,2010,NCI,1ZIABC010816-04,,Immunotherapy for Malignant Mesothelioma,"HASSAN, RAFFIT",NIH,,"$809,969"
Lung Cancer,2010,NCI,1ZIABC010874-03,,Biomarkers of Human Lung Cancer,"HARRIS, CURTIS",NIH,,"$740,964"
Lung Cancer,2010,NCI,1ZIABC010891-03,,Antibody Therapy of Cancer,"HO, MITCHELL",NIH,,"$464,972"
Lung Cancer,2010,NCI,1ZIABC011046-03,,Mechanisms of apoptosis regulation which impede cancer cell death in lung cancer,"KWONG, KING",NIH,,"$304,097"
Lung Cancer,2010,NCI,1ZIABC011049-03,,Development and evaluation of apoptosis targeted therapies in lung cancer,"KWONG, KING",NIH,,"$390,981"
Lung Cancer,2010,NCI,1ZIABC011108-03,,MAP Kinase signal transduction disruption in cancer,"WIEST, JONATHAN",NIH,,"$242,236"
Lung Cancer,2010,NCI,1ZIABC011115-03,,Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells,"SCHRUMP, DAVID",NIH,,"$686,463"
Lung Cancer,2010,NCI,1ZIABC011122-03,,Epigenetic Alterations Induced by Tobacco Smoke,"SCHRUMP, DAVID",NIH,,"$800,874"
Lung Cancer,2010,NCI,1ZIABC011160-02,,Mechanisms in development  and  regulation of metastasis in lung cancer,"KWONG, KING",NIH,,"$173,769"
Lung Cancer,2010,NCI,1ZIABC011167-02,,A novel preclinical model of spontaneous metastasis,"MERLINO, GLENN",NIH,,"$434,638"
Lung Cancer,2010,NCI,1ZIABC011188-02,,Diazeniumdiolates as Broad-Spectrum Anticancer Agents,"KEEFER, LARRY",NIH,,"$789,453"
Lung Cancer,2010,NCI,1ZIABC011204-02,,Preclinical development of AlaTIMP-2 as an cancer therapeutic,"STETLER-STEVENSON, WILLIAM",NIH,,"$941,406"
Lung Cancer,2010,NCI,1ZIABC011212-02,,Functions of IKKalpha in Skin Homeostasis and Skin Tumorigenesis,"HU, YINLING",NIH,,"$994,328"
Lung Cancer,2010,NCI,1ZIABC011217-02,,Preclinical Characterization of Drugs in Mouse Model of Lung Cancer,"VAN DYKE, TERRY",NIH,,"$1,329,129"
Lung Cancer,2010,NCI,1ZIABC011268-01,,Lung Cancer Stem Cell program,"GIACCONE, GIUSEPPE",NIH,,"$322,530"
Lung Cancer,2010,NCI,1ZIABC011269-01,,Thorarcic Cancer Research Laboratory,"GIACCONE, GIUSEPPE",NIH,,"$1,182,610"
Lung Cancer,2010,NCI,1ZIACP000150-06,,Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"TAYLOR, PHILIP",NIH,,"$2,367,562"
Lung Cancer,2010,NCI,1ZIACP000176-06,,Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"TAYLOR, PHILIP",NIH,,"$97,710"
Lung Cancer,2010,NCI,1ZIACP005804-16,,Pharmacogenetic Studies,"CAPORASO, NEIL",NIH,,"$988,591"
Lung Cancer,2010,NCI,1ZIACP010120-15,,Studies of Occupational Cancer,"LAN, QING",NIH,,"$2,553,424"
Lung Cancer,2010,NCI,1ZIACP010125-15,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$1,948,414"
Lung Cancer,2010,NCI,1ZIACP010169-09,,"Nutrition, Metabolism, and Cancer","ZIEGLER, REGINA",NIH,,"$159,895"
Lung Cancer,2010,NCI,1ZIACP010184-08,,Consultation and Collaboration,"GRAUBARD, BARRY",NIH,,"$469,093"
Lung Cancer,2010,NIDDK,1ZIADK053101-22,,Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors,"JENSEN, ROBERT",NIH,,"$619,542"
Lung Cancer,2010,NCI,1ZIASC000167-19,,Molecular Pathology of Pulmonary Carcinogenesis,"LINNOILA, ILONA",NIH,,"$1,169,604"
Lung Cancer,2010,NCI,1ZIASC010292-12,,Signal Transduction Pathways that Promote Survival of Lung Cancer Cells,"DENNIS, PHILLIP",NIH,,"$1,169,414"
Lung Cancer,2010,NIA,1ZICAG000617-03,,Application of analytical cytology to current issues in the biomedical sciences,"WERSTO, ROBERT",NIH,,"$15,111"
Lung Cancer,2010,NCI,1ZICBC010630-07,,Cancer Vaccines and Modulation of Checkpoint Controls in Immunization,"JANIK, JOHN",NIH,,"$593,182"
Lung Cancer,2010,NCI,1ZICBC010964-03,,Trans-NIH Angiogenesis Core Facility,"CUTTITTA, FRANK",NIH,,"$855,331"
Lung Cancer,2010,NCI,1ZICBC011040-03,,Molecular Profiling of Clinical Specimens,"EDELMAN, DANIEL",NIH,,"$1,607,934"
Lung Cancer,2010,NCRR,5M01RR000188-46,6638,ADMINISTRATION OF HER2 CHIMERIC RECEPTOR AND TGFBETA DOMINANT NEGATIVE RECEPTOR,"GOTTSCHALK, STEPHEN",BAYLOR COLLEGE OF MEDICINE,TX,"$2,289"
Lung Cancer,2010,NCRR,5M01RR000865-37,6968,A PHASE I TRIAL OF CCL-21 GENE MODIFIED DENDRITIC CELLS IN NON-SMALL CELL LUNG,"LEE, JAY",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$1,319"
Lung Cancer,2010,NCRR,5P20RR018787-08,7309,COBRE P1: MOLECULAR MECHANISMS OF AURORA KINASE A DYSFUNCTION IN LUNG CANCER,"GERBER, SCOTT",DARTMOUTH COLLEGE,NH,"$265,300"
Lung Cancer,2010,NCRR,5P20RR016472-10,7408,INTERACTIVE COMPUTER-AIDED DIAGNOSIS TOOLS FOR GROUND-GLASS OPACITY LUNG TUMORS,"KAMBHAMETTU, CHANDRA",UNIVERSITY OF DELAWARE,DE,"$75,552"
Lung Cancer,2010,NCI,261201000018C-0-0-1,,TAS::75 0849::TAS ANTIBODY ARRAY FOR DETECTION OF LUNG CANCER,"STENGELIN, MARTIN","MESO SCALE DIAGNOSTICS, LLC",MD,"$799,999"
Lung Cancer,2010,NCRR,5P41RR001192-31,5360,HIGH RESOLUTION OPTICAL DIAGNOSTICS FOR ORAL AND LUNG CANCER,"CHEN, ZHONGPING",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$3,397"
Lung Cancer,2010,NCRR,5P41RR018502-08,6713,TRANSCRIPT ANALYSIS OF LUNG CANCER CELL LINES,"MOREMEN, KELLEY",UNIVERSITY OF GEORGIA (UGA),GA,"$2,610"
Lung Cancer,2010,NCRR,5P41RR005959-21,7492,HYPERPOLARIZED 3HE MR-LUNG CANCER LESIONS TAGGED BY TARGETED SPIONS,"BRANCA, ROSA",DUKE UNIVERSITY,NC,"$10,920"
Lung Cancer,2010,NCRR,5P41RR005959-21,7494,IMAGING LUNG CANCER IN MICE TO IMPROVE RADIATION THERAPY,"KIRSCH, DAVID",DUKE UNIVERSITY,NC,"$21,840"
Lung Cancer,2010,NCRR,5P41RR005959-21,7498,ROLE OF HUMORAL IMMUNITY IN METASTASIS,"PATZ, EDWARD",DUKE UNIVERSITY,NC,"$5,460"
Lung Cancer,2010,NCRR,5P41RR005959-21,7536,IMAGING OF MOUSE LUNG TUMORS WITH FLUORESCENCE TOMOGRAPHY / MICROCT,"ZHANG, XIAOFENG",DUKE UNIVERSITY,NC,"$5,460"
Lung Cancer,2010,NCRR,5P41RR013461-12,7606,FEASIBILITY OF NANOPARTICLE-MEDIATED PACLITAXEL DELIVERY,"LAM, KIT",UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB,CA,"$16,992"
Lung Cancer,2010,NCRR,5P51RR000163-51,5197,ACETYLCHOLINE AND NICOTINIC RECEPTORS IN LUNG CANCER,"SPINDEL, ELIOT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$46,653"
Lung Cancer,2010,NIA,5P51RR000163-51,5197,ACETYLCHOLINE AND NICOTINIC RECEPTORS IN LUNG CANCER,"SPINDEL, ELIOT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,$950
Lung Cancer,2010,NCRR,5P51RR000163-51,5255,CHOLINE TRANSPORTERS SPECIFICALLY TARGET NON-NEURONAL ACETYLCHOLINE SYNTHESIS,"SONG, PILL-SOON",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$46,653"
Lung Cancer,2010,NIA,5P51RR000163-51,5255,CHOLINE TRANSPORTERS SPECIFICALLY TARGET NON-NEURONAL ACETYLCHOLINE SYNTHESIS,"SONG, PILL-SOON",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,$950
Lung Cancer,2010,NCRR,5M01RR000425-41,5988,TRANSCRIPTIONAL REGULATION OF A FUMIGATUS VIRULENCE,"FILLER, SCOTT",LA BIOMED RES INST/ HARBOR UCLA MED CTR,CA,"$4,147"
Lung Cancer,2010,NCI,1ZIABC010448-09,,Genetic Alterations in Lung Cancer,"WIEST, JONATHAN",NIH,,"$242,236"
Lung Cancer,2010,NCI,1ZIABC010449-09,,Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung,"KIMURA, SHIOKO",NIH,,"$546,151"
Lung Cancer,2010,NCI,1ZIABC011332-01,,Tumor Microenvironment in Cancer Progression,"KAPLAN, ROSANDRA",NIH,,"$13,124"
Lung Cancer,2010,NCI,1ZIACP010134-15,,Studies of Atomic Bomb Survivors,"BERRINGTON, AMY",NIH,,"$651,468"
Lung Cancer,2010,NCI,1ZIASC007256-22,,Mechanisms of Oncogene Action in Tumorigenesis,"KAYE, FREDERIC",NIH,,"$335,206"
Lung Cancer,2010,NCI,1ZIACP010200-03,,GEI - Genome-Wide Association Studies,"FRAUMENI, JOSEPH",NIH,,"$245,583"
Lung Cancer,2010,NCI,1ZIASC010093-14,,Targeting the Epigenome for Lung Cancer Therapy,"SCHRUMP, DAVID",NIH,,"$800,874"
